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Single-nucleotide polymorphisms (SNPs) in DNA and abnormal expression of 
microRNAs (miRNAs) are two significant types of abnormalities of nucleic 
acids. Recent studies have revealed that numerous diseases, including various 
types of cancer and metabolic syndromes, are originated from these two types 
of abnormalities. These facts intrigued scientists to find methods to qualitatively 
and quantitatively discriminate disease-related DNAs and miRNAs. The works 
in this thesis focuses on establishing colorimetric, fluorescent, and 
electrochemical bioassays for the detection of disease-related nucleic acids. 
 
Chapter 1 gives an introduction of the two types of disease-related nucleic acids 
and the necessity to detect them. Representative detection techniques developed 
previously for genotyping and quantifying SNPs in DNA as well as for profiling 
expression levels of miRNAs will be reviewed and discussed.  
 
Chapter 2 presents a ferrofluid-based homogeneous bioassay for highly 
sensitive and selective detection of SNPs. The assay utilized a ligase as a target 
amplifier through ligase chain reaction (LCR) and ferrofluidic nanoparticle 
probes (FNPs) as signal generators and amplifiers at the same time by catalyzing 
the colorimetric oxidation of 3,3’,5,5’-tetramethylbenzidine. The exponential 
amplification ability of the LCR and FNP-catalyzed signal amplification offered 
the assay excellent sensitivity and selectivity as well as low limit of detection. 
The attractive properties of simple, rapid and low cost colorimetric SNP 
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genotyping could open a new perspective in the development of SNP 
genotyping tools for uses at point-of-care. 
 
Chapter 3 demonstrates a simple and highly sensitive fluorescence assay for the 
detection of miRNAs. Briefly, fluorescein-capped DNA detection probes were 
first conjugated to magnetic beads (MBs) for capturing target miRNA let-7a. A 
duplex-specific nuclease (DSN) was engaged to selectively cleave the DNA 
probes in the miRNA-DNA duplexes and release the target miRNA strands back 
to solution, thereby establishing a target recycling amplification mechanism and 
a cumulative signal amplification process. The remained DNA detection probes 
were completely removed when the MBs were separated by permanent magnet, 
attaining a negligible background. The high specificity of the DSN to perfectly 
matched duplexes, the accumulative signal amplification in association with a 
negligible background endowed this assay a good sensitivity and selectivity 
when analyzing target miRNAs with high sequence similarities.  
 
Chapter 4 and 5 illustrate an electrochemical bioassay for miRNAs. Before 
demonstrating the assay, Chapter 4 first discusses a novel and environmentally 
friendly reaction – the synthesis of polyaniline (PANI) via DNAzyme-catalyzed 
polymerization of aniline, which was firstly thoroughly investigated and then 
applied to the assay for signal output. The electrochemical impedance 
spectroscopy (EIS)-based bioassay described in Chapter 5 utilized charge 
neutral peptide nucleic acid (PNA) as capture probes (CPs) to hybridize with 
target miRNA, which in turn guided the deposition of insulating PANI on the 
surface of a substrate electrode. Consequently, an electrochemical impedimetric 
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signal was produced. The signal amplification and sensitivity improvement 
were conveniently achieved by the catalytic reaction and excellent mismatch 
discrimination capability was observed due to the excellent hybridization 
selectivity of PNA CPs.  
 
Chapter 6 gives a summary of the above-mentioned projects with some 
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Chapter 1. Introduction 
 
It has been found that nucleic acids, including deoxyribonucleic acid (DNA) 
and ribonucleic acid (RNA), provide genomic templates1 to determine the 
amino acid sequences along the polypeptide chain of protein,2 and thus play a 
critical role in all activities of living beings. For example, nucleic acids encode 
genetic instruction and regulate the cell growth, cell development, cell 
proliferation and  differentiation, cell apoptosis, and neuronal patterning etc.3 
Recent studies have revealed that numerous diseases,4, 5 including various types 
of cancer like breast cancer6 and lung cancer,7, 8 and metabolic syndromes like 
cardiovascular disease9 and diabetes,10 originate from the abnormalities of 
nucleic acids. These facts intrigued scientists to find methods to qualitatively 
and quantitatively detect nucleic acids, especially the disease-related ones.  
 
1.1 Disease-related nucleic acids 
1.1.1 Single-nucleotide polymorphisms in DNA 
Single-nucleotide polymorphisms (SNPs) belong to DNA sequence variations11 
and are defined as single base-pair positions where variable alleles exist.12 They 
are referring to single base transversion (switch among purines and pyrimidines) 
as well as base transition (switch between purines or pyrimidines only), but 
normally do not include single base insertion or deletion. Because DNA are 
made of  four kinds of nucleobases i.e. A, T, C and G, SNPs theoretically could 
be up to tetra-allele polymorphisms; while in fact, tri- or tetra-allele 
polymorphisms almost do not exist in human DNA. This is the reason that SNPs 
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are regarded as one type of bi-allele polymorphisms and can be simply noted as 
+/− during a certain SNPs genotyping and quantification.    
 
During the 1990s, as the most abundant DNA variations,13 SNPs attracted wide 
attention along with the progress of Human Genome Project. In the past two 
decades, intensive research efforts have been devoted to the study of SNPs. 
Computational analysis has predicted that there are over 15 million SNPs in the 
human genome occurring on an average of one SNP in every 200 nucleotides.14 
SNPs are believed to be closely associated with various medical conditions and 
genetic diseases although the majority of them have little impact on human 
health.5, 15, 16 Information gathered to date suggests that SNPs may serve as a 
new generation of biomarkers for cancer diagnosis and prognosis,5, 15, 16 
presenting clinical scientists with new perspectives in diagnostics and a 
promising therapeutic frontier. 
 
Because of their prominent relevance to human health, the identification of 
clinically relevant SNPs has become a major initiative in molecular biology 
research. The establishment of the relationship between typical SNPs with 
diseases has prompted research on SNP genotyping and quantification 
techniques. Since SNPs are considered as the next generation of biomarkers, 
there is growing demand for researchers to develop simple and robust 
techniques that allow rapid, sensitive and selective genotyping, and 




1.1.2 Abnormal expression of miRNA 
MicroRNAs (miRNAs) are a class of single-stranded, highly conserved,17 non-
coding, regulatory RNAs derived from an approximately 70-nucleotide long 
hairpin stem-loop precursor known as pre-miRNAs.18 After the pre-miRNAs 
are cleaved by the ribonuclease Dicer, mature miRNAs with lengths of 22 
nucleotides are formed.19, 20 The whole process that how mature miRNAs 
formed can be seen in Figure 1-1.21 
 
Figure 1-1. Schematic of the process of the production of mature miRNAs. 




MiRNAs exist in a wide range of living creatures including animals, plants and 
even viruses. The first miRNA, lin-4, was discovered in C. elegans by Victor 
and colleagues in 1993;22 while it has not been regarded as a distinct class of 
biological regulator until the early 2000s when miRNAs were found playing a 
vital regulatory role in gene expression20 and cell differentiation through their 
incorporation into the RNA-induced silencing complexes (RISC), which either 
inhibit the translation of imperfectly matched messenger RNAs (mRNAs) to 




Figure 1-2. MicroRNAs function as biological regulators through their 
incorporation into the RISC: (a) degrade the perfectly matched mRNAs and (b) 
inhibit the translation of imperfectly matched mRNA. (Reprinted from 
reference 21, with permission from Elsevier) 
 
Along with the continuing identification of many more miRNAs, it is believed 
that over 50% of all protein encoding genes in humans are regulated by 
miRNAs.23, 24 Increasing evidence has shown that, in addition to their regulatory 
roles in gene expression, miRNAs are linked to various physiological and 
pathological processes, and human malignancies in particular25, 26 For example, 
it was observed that in the serum of ovarian cancer patient, miRNA-21, -29a, -
92, -93, and -126 are obviously over-expressed compared with a healthy 
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person.27  In the plasma of gastric cancer patients, the expression level of let-7a 
is lower whereas the miRNA-17-5p, -21, -106a and -106b are significantly 
higher than the a normal person.28 Lu et al. observed that a down-regulation of 
miRNA expression is an emerging feature in cancer and specific dysregulation 
of certain miRNAs is seen in specific cancer types.29 What is more, miRNA 
expression profiles can be used to classify poorly differentiated tumor 
successfully while the mRNA profile counterparts are highly inaccurate under 
the same conditions.29 It was also believed that miRNAs are directly associated 
with medical conditions of patients including their individual responses to 
diseases, drugs, and other environmental factors. Therefore, studies of miRNAs 
expression levels have great potential in therapeutics, drug discovery, and 
molecular diagnostics.29, 30 The function of miRNA in the regulation and the 
corresponding mechanism are summarized and discussed in detail in two 
recently published review articles.31, 32 
 
Provided that a correlation between the miRNA expression level and the state 
of an illness can be established, the expression levels of miRNAs can be used 
to indicate if a person is not in a good health condition and advance treatments 
can be applied before disease deterioration. Thus, similar to the SNPs in DNA, 
miRNAs can also be considered as the biomarkers for early disease diagnosis, 
prognosis and in-time therapy. Because of their close association with human 
health, abnormal levels of miRNA expression must be reliably identified and 




As aforementioned, diagnosis and prognosis of disease-related nucleic acids at 
early stage before symptoms appear will enable in time prevention and 
treatment to minimize the impairment may be induced by the diseases and could 
help to reduce the mortality rate of patients. This is the ultimate goal that 
researchers are pursuing and during the past few decades, it continuously guides 
researchers to investigate and develop effective methods to realize the early 
diagnosis and prognosis of disease-related nucleic acids. 
 
As we know, the simplest method to detect the presence or the amount of nucleic 
acids is to measure the ultraviolet-visible (UV-Vis) absorbance at a wavelength 
of 260 nm, which is usually noted as optical density at 260 nm (OD260). 
However, the abnormalities of nucleic acids, including single-nucleotide 
mutation (which results in SNPs) within a specific type of nucleic acids as well 
as the abnormal expression level of a kind of regulating nucleic acids (such as 
miRNAs) with specific sequence, are usually in rather low concentrations. The 
basic UV-Vis method is far from sensitively detecting nucleic acids in low 
concentration even with quality control OD260/280 ≥ 1.8 and OD260/320 ≥ 1.8 
considering effect of pH and ionic strength33 as well as the interference from 
numerous substances that also absorb UV-Vis light around 260 nm. More 
importantly, it is incapable of detecting nucleic acids with a particular sequence, 
not to mention the ability to selectively genotype SNPs or discriminate a certain 
miRNA from its similar family members. Therefore, nucleic acid bioassays with 
adequate sensitivity and sequence selectivity/specificity are urgently needed. 
More sensitive and selective bioassays/techniques with superior sequence 
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discrimination ability need to be developed for the detection of disease-related 
nucleic acids.  
 
1.2 General principle of nucleic acid detection 
During the past few decades, numerous bioassays for the detection of nucleic 
acids have already been developed. Generally, the assay procedure consists of 
two main steps. First, under proper conditions of salt concentration and 
temperature, the nucleic acids of interest (i.e. target) hybridize to a recognition 
bioreceptor/probe (usually an oligonucleotide with sequence fully 
complementary to the target) through Watson-Crick base pairing and 
subsequently result in a signal. Second, this signal will then be amplified and 
transduced to another measurable signal that can be collected by a readout 
device in a customer-desired way, sometimes in real time.13 As for quantitative 
detection, the final output signal is proportional to the amount of the original 
target nucleic acids present in the sample solution, and thus the concentration 
of target can be quantified.  
 
1.3 Detection techniques of disease-related nucleic acids 
According to the detection techniques used for the final output signal 
measurement, widely used nucleic acids detection methods can be classified to 
optical detection, electrochemical detection, gravimetric detection, 
piezoelectric detection, thermometric detection, etc.34, 35 Currently, the 
detection methods for nucleic acids are mainly optical detection and 
electrochemical detection. Their more detailed classification 21, 34 based on the 
final signal output can be seen in Table 1-1.  
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Table 1-1. Classification of optical detection and electrochemical detection 
methods for nucleic acids based on the final signal output. 
Optical detection 
Colorimetric detection36 
Fluorescent detection 37 
Surface Plasmon Resonance (SPR) detection38 
Surface Enhanced Raman Scattering (SERS) 
detection39 








Herein, the discussion in the following sections will focus on colorimetric 
detection, fluorescent detection, and impedimetric detection which are closely 
relevant to the projects in this thesis. The advantages and limitations of these 
detection methods will be discussed accordingly in the following sections. And 
possible measures to establish novel, highly sensitive and selective bioassays 
for nucleic acids will be proposed.  
 
1.3.1 Colorimetric detection 
Colorimetric detection is one of the two most prevailing optical detection 
methods for nucleic acids. It is a method based on Beer-Lambert law which 
establishes a direct linear correlation between the absorbance and the 
concentration of a substance within a certain range.45 The final signal can be 




At the beginning of 1980s, most of the colorimetric detections relied on biotin-
labeled oligonucleotides as detection probes and gel electrophoresis as the final 
signal output device.46 It was Murasugi47 who firstly detected target DNA with 
the biotin-labeled oligonucleotides. Later, this method was followed and further 
developed by Riley and his colleagues.48, 49 However, gel electrophoresis is 
labor-intensive and time-consuming that are not welcomed by researchers. 
What is more, detection of nucleic acids at this stage cannot unambiguously 
determinate DNAs with different sequences.  
 
The colorimetric detection has not been developed at a large scale until 1990s, 
when Travascio50, 51 revealed the intrinsic catalytic activity of DNA and 
designed a DNAzyme (PS2.M), which can catalyze a series of oxidation 
reactions and produce UV-Vis spectrometer-detectable signals. The DNAzyme 
was then used for developing colorimetric bioassays for DNA.52, 53 The final 
signal readout platform, i.e. UV-Vis spectrometer, became much simpler and 
faster, and sequence distinguishability was also achieved with an intelligent 
design of DNAzyme at that time. 
 
The advantages that colorimetric bioassays exhibited are simple mechanism to 
be understood, inexpensive instrument, easy operation, stable signal, high 
repeatability, fast detection, and a wide range of applications.34 However, the 
sensitivity of direct colorimetric bioassays is relatively low and the limit of 
detection (LOD) is not low enough. Advanced materials and/or pre-signal 
amplification need to be coupled into this type of bioassays to improve their 
sensitivity and decrease the LOD. In 1996, Mirkin and co-workers54 judiciously 
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designed the first colorimetric DNA detection method coupling with gold 
nanoparticles (AuNPs). This milestone work enabled the AuNPs to become the 
most popularly used nanomaterials in colorimetric bioassays to improve the 
sensitivity and decrease the LOD.55 Nonetheless, gold is an expensive material 
that makes the bioassays unfavorable to some extent. Consequently, cheaper 
nanomaterials have been explored to replace the AuNPs while still retaining 
their attractive features.  
 
1.3.2 Fluorescent detection 
Fluorescent detection is the other one of the two most prevailing optical 
detection methods for nucleic acids. It is based on the fact that electrons in a 
fluorophore can absorb photons and be excited from the ground electronic state 
(lower energy level) to  excited states (higher energy levels), and when the 
electrons relax to the ground state, light is emitted and it can be collected by a 
spectrofluorometer.  
 
During early years, fluorescent dyes were always used as probes for the 
fluorescent detection of nucleic acids.56 However, the use of large dose of dyes 
to stain the target nucleic acids is quite toxic and environmentally unfriendly. 
Besides, the dyes are not sequence selective and thus cannot be used for the 
detection of nucleic acids with certain sequences. Molecular beacons that have 
nucleic acid sequence discrimination ability designed by Tyagi and Kramer in 
1996 brought great progress for the fluorescent detection of nucleic acids.57 
After that, a new generation of fluorescent bioassays was established and 
fluorescent detection of nucleic acids became much more sensitive and 
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sequence distinguishable.58, 59 Soon, various designs of molecular beacon-based 
probes were created and utilized in fluorescent bioassays to decrease the LOD 
as well as to enhance the detection sensitivity and specificity of nucleic acids.60 
In recent years, fluorescent detection was coupled with polymerase chain 
reaction (PCR) and it is now the gold standard for nucleic acids detection due 
to its high sensitivity and selectivity as well as ultralow LOD.61  
 
However, fluorescent bioassays have their own limitations like photo bleaching, 
the need of additional fluorescent dyes which would expose high toxicity to live 
samples, complex operation and expensive equipment.62, 63 The gold standard, 
i.e. PCR-based fluorescent detection of nucleic acids, needs quite complicated 
pre- and post-PCR treatment procedures, expensive equipment, and is labor-
intensive. Thus, cost-control and procedure-simplification are essential 
regarding this type of detection.  
 
1.3.3 Impedimetric detection 
Impedimetric detection is one of the most important electrochemical detection 
methods. The earliest electrochemical nucleic acids detection strategy should 
be traced back to 1960s when Palecek64 found that nucleic acids can be analyzed 
based on the redox reaction of nucleic acids at a mercury electrode. Later, 
electrochemical methods for the detection of nucleic acids received substantial 
attention and numerous electrochemical bioassays have been developed during 




Impedimetric detection of nucleic acids involves electrochemical impedance 
spectroscopy (EIS) for the signal collection. It measures the charge-transfer 
resistance (Rct) of an electrochemical system and the data are fitted to an 
electrical circuit – usually Randle equivalent circuit – and produce an EIS 
spectrum.66, 67 The semicircle in the EIS spectrum is closely associated with the 
charge transfer of the probe and its diameter indicated the Rct. The value of Rct 
can thus be conveniently obtained from the EIS spectrum. Large Rct indicated 
that a large amount of charge-transfer impeding material is present at the 
electrode surface. Base on this mechanism, Peng et al. established an 
impedimetric detection method for disease-related nucleic acids by the 
deposition of an insulating polymer film on the surface of the electrode.41 The 
excellent sensitivity, ultralow LOD, inherent miniaturization, and good 
compatibility with standard microfabrication and semiconductor technologies 
make this method quite appealing for the detection of disease-related nucleic 
acids.   
 
Homogenous bioassays such as some colorimetric bioassays and fluorescent 
bioassays can always achieve good reproducibility; while in contrast, as a kind 
of typical heterogeneous bioassays, electrochemical bioassays are inferior when 
referring to this aspect. Nevertheless, the main advantage of electrochemical 
bioassays is their good sensitivity and low LOD compared to other bioassays. 
Furthermore, low power requirement, less cost, portable system, and good 
compatibility also endow electrochemical bioassays a significant position in the 




According to the various requirements of the detection techniques, numerous 
bioassays have already been established for the detection of nucleic acids. 
Nevertheless, each of them has its own disadvantages that limit its wide-spread 
applications. None of the current bioassays can cover all aspects including high 
sensitivity, low LOD, high selectivity, low cost, concise procedure, rapid 
detection, good repeatability, etc. One or more aspects would be sacrificed when 
a particular detection needs to meet a specific criterion. Further development 
for each type of bioassays is necessary to address its own weaknesses and make 
full use of its advantages and benefits. The gaps and aims of this thesis are 
summarized as the following: 
 Colorimetric bioassays have relatively inferior sensitivity and LOD. 
Thus advanced technology and effective signal amplification strategies have to 
be introduced to improve its sensitivity and decrease the LOD.  
 Fluorescent bioassays are more expensive and involve more 
complicated procedures. In this thesis, judicious design will be made to simplify 
the assay process and decrease the cost of the assay. 
 Impedimetric bioassays have relatively inferior repeatability but have 
good sensitivity and low LOD. Generally the worse the repeatability will be 
when more steps are involved in a bioassay. Project in this thesis will develop 
an assay with simplified procedure, so that better repeatability can be obtained 




1.4 Detection of SNPs in DNA 
1.4.1 Difficulties in the detection of SNPs in DNA 
As the first step toward improving human health, SNPs must be reliably 
identified and quantified. However, the intrinsically subtle difference between 
wild-type and mutant genes – a single-base variation – makes it a challenging 
task specifically to detect low-abundance SNPs out of a large amount of a wile-
type gene. Ideally, SNP genotyping and quantification techniques should be 
rapid, robust, fully automatic, highly accurate, and affordable.68  
 
1.4.2 Developed SNP genotyping and quantification techniques 
To date, three groups of SNP genotyping and quantification techniques have 
been developed. They are allele-specific hybridization-based techniques, allele-
specific enzymatic techniques, and sequencing techniques.  
 
1.4.2.1 Allele-specific hybridization-based techniques 
Allele-specific hybridization-based techniques leverage on the subtle difference 
in affinity for the formation of SNP target-capture probe duplexes. In other 
words, it relies on the thermal stability arising from the single-nucleotide 
variation between a wild-type and a mutated gene.69 In most cases, the 
hybridization of allele-specific hybridization bioassays is firstly performed on 
solid substrates, which will benefit the separation of interfering species, and 





For example, Lambert and his colleagues used a commercial SPR sensor and 
modified DNA probes on it for rapid detection of a 21-base long DNA target. 
One-base mismatch can be distinguished (without the co-existing interfering 
mismatches) and the detection limit was 100 pM.70 Since this type of techniques 
does not require the involvement of complex enzymatic reactions, nor the use 
of detection probes, it is straightforward, label-free, fast, cost-effective, 
convenient, and easy to be conducted. Nevertheless, simply relying on the 
detection of subtle difference in stability caused by a single base variation 
suffers from the problems of low selectivity and inferior sensitivity on the other 
side.71 LOD at picomolar level is not good enough and the selectivity when 
interfering mismatches exist is far from satisfactory for SNP genotyping and 
quantification. 
 
In order to achieve an acceptable selectivity and better sensitivity as well as 
lower LOD, great care must be taken in the optimization of the hybridization 
conditions such as salt concentration and incubation temperature. Besides, 
secondary structure in the DNA probes, including molecular beacons, Y-shape 
junction, toeholds, and G-quadruplexes were designed and employed to achieve 
this goal.  
 
Molecular beacons are stem-loop structured oligonucleotides that contain both 
fluorescent reporters and quenchers. The fluorescence of the reporters is 
quenched when the oligonucleotides fold into stem-loops by fluorescence 
resonance energy transfer (FRET) between the reporters and quenchers. The 
fluorescence of the reporters is restored when complementary target strands 
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hybridize and unfold the stem-loops.57 The first application of molecular 
beacons in SNP genotyping was reported by Kramer and co-workers.72 Two 
molecular beacons respectively labelled with fluorescein and tetramethyl 
rhodamine were employed to detect wild-type and mutant genes selectively. 
With the continuing progress of research, many derivatives of molecular 
beacons have been developed, such as super-quencher molecular beacons,73 
quencher-free molecular beacons,74 and stemless molecular beacons.75 All of 
the derivatization strategies are used to increase the sensitivity and specificity 
of SNP genotyping. 
 
Y-shaped junction probes are specifically-designed DNA strands that form Y-
shaped junctions upon folding. Based on a template-enhanced hybridization 
process, Y-shaped junction probes are utilized for SNP genotyping 
isothermally. For example, Zhang et al. reported an electrochemical SNP 
genotyping strategy for oral cancer employing the Y-shaped junction probes and 
deoxyinosine nucleoside substitution on SNP sites. An LOD at 130 fM was 
obtained by linear sweep voltammetry.76 Yeh et al. also developed an assay for 
the detection of SNP based on the termed Chameleon NanoCluster beacon 
(cNCB) probes. When a target DNA was exposed to the two segments of the 
cNCB probes, the Y-shaped junction DNA structure was generated; while one-
base mismatched strand presented, a frame shift in one of the arms of the Y-
shape junction caused a color change of silver nanocluster, which can be 




A toehold is a short, single-stranded, overhanging region in double-stranded 
DNA (dsDNA).71 A fast strand-displacement reaction (SDR) occurs when a 
totally-complementary oligonucleotide binds to the toehold with replacement of 
the original short double strand by the oligonucleotide.78 Application of toehold 
in SNP detection was first proposed by Zhang and his colleagues in 2010 using 
a DNA-origami platform. The DNA origami was constructed in a way that it 
contained a line of protruding linear capture probes, capable of forming toeholds 
with biotinylated, partially complementary reporting probes. Streptavidin was 
used as a contrast label to reveal the position of the reporting probes. When 
target DNA was employed, SDR occurred and reflected by the disappearance 
of the streptavidin feature on the DNA-origami platform.79 Later, based on 
locked nucleic acid (LNA) and the toehold structure, Gao et al. developed and 
ON-OFF switching SNP assay.80 The immobilized probes first hybridized with 
methylene blue-tagged capture probes and the signal was ON. After introducing 
the target DNA, the toehold on the capture probes initiate the SDR and switch 
OFF the signal; while when the one-base mismatch presented, SDR was 
forbidden and the signal is still ON. By replacing the normal nucleotide on 
capture probes with LNA at the SNP site, the ability to discriminate SNP mutant 
sequence significantly improved. The discrimination factor of the assay was as 
high as 6000 and the LOD was found to be 58 pM. 
 
A G-quadruplex is a four-stranded structure assembled from a guanine-rich 
oligonucleotide.81 It is likely to coordinate with metal ions and can be bound by 
hemin to form a peroxidase-like complex – DNAzyme.82 Kolpashchikov et al. 
reported an SNP assay based on DNAzyme, which was separated into two 
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segments with four triple-guanine sequences split in a 2 + 2 pattern. In the 
presence of a target DNA, the binding arms formed a DNAzyme with hemin for 
the consequent DNAzyme-catalyzed colorimetric signal output.83 The 
mismatch cannot induce the formation of DNAzyme and thus no signal was 
produced. This concept of G-quadruplex was further developed by Wang and 
his co-workers.84, 85 The performance of this type of SNP genotyping assay was 
significantly improved by incorporating more complex procedures.  
 
Even so, it remains a formidable task to detect SNPs selectively in the presence 
of a large excess of the wild-type gene, which poses a considerable threat to the 
target. After all, hybridization is thermodynamics driven. Much effort, like 
powerful target amplification and/or signal amplification strategies fully 
compatible with the allele-specific hybridization, has therefore been devoted to 
overcome these problems. For example, Gao et al. introduced mismatch-
eliminating nucleases and used an electrochemical platform for signal 
transduction as well as signal amplification. It was demonstrated that nucleases 
are capable of eliminating all imperfectly-hybridized interfering DNA strands 
as well as unhybridized probes. The hybridized SNP target-capture probe 
duplexes can serve as the templates to guide the deposition of polyaniline 
(PANI); and the deposited PANI then served as a signal generator in the 
construction of an electrochemical biosensor for highly sensitive and selective 
SNP genotyping. What needs attention here is that the nucleases are only used 
to clean up, not for signal transduction and amplification. This should not be 




1.4.2.2 Allele-specific enzymatic techniques 
Allele-specific enzymatic techniques rely on the discrimination and 
amplification power of the utilized enzymes to achieve better selectivity and 
sensitivity as well as lower LOD. Similar to the allele-specific hybridization-
based techniques, most of the allele-specific enzymatic techniques are also 
performed on solid supports in order to separate enzymatic reaction products 
conveniently from the reaction mixture and for the easy configuration of 
multiplexed assays. It is also desirable that the enzymatic reactions be carried 
out in a homogeneous or nearly homogeneous manner to have a good control 
over the whole assay process and obtain a better repeatability.  
 
Generally, this type of techniques is much better than that of their allele-specific 
hybridization-based counterparts with respect to selectivity, which primarily 
originates from the high selectivity of the enzymatic reactions and two 
recognition events, i.e. the hybridization of the allele-specific probes and 
common probes to adjacent positions with SNP targets. The major downsides 
of the allele-specific enzymatic reaction-based SNP genotyping and 
quantification techniques are their high cost and sometimes time-consuming 
multistep protocols. This is the price needed to pay when superior sensitivity 
and selectivity as well as lower LOD are pursued. Widely employed allele-
specific enzymatic techniques are enzymatic ligation, primer extension, and 
enzymatic cleavage which are discussed in the following sections.  
 
The principle of the allele-specific enzymatic ligation technique lies in the 
covalent ligation of two adjacent probes that are connected at or near an SNP 
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site by a ligase. The ligase was first introduced to SNP genotyping by Landegren 
et al. in 1988 and one-base mismatch was successfully detected by 
fluorometry.86 This technique provided a novel and rapid way to discriminate 
SNP in genomic DNA. In order to significantly enhance the sensitivity and 
decrease the LOD, it was further developed through coupling to amplification 
techniques like ligase chain reaction (LCR), and advanced materials like silver 
nanoparticles (AgNPs) and AuNPs. For example, He et al. showed that 
picomoles to nanomoles of DNA with single-base mismatches can be visualized 
with a lateral flow strip biosensor by using AuNPs and hairpin oligonucleotides 
with double-target DNA binding sequences87 or hairpin-functionalized 
AuNPs.88 Since non-functionalized AuNPs used for the colorimetric detection 
of DNA sequences was first reported by Li et al.,89 AuNPs were continuously 
investigated and coupled to allele-specific enzymatic ligations to improve the 
performance of SNP genotyping. Liu and colleagues designed an SNP chip 
utilizing the optical properties of AuNPs, which were further promoted by silver 
enhancement and a ligation reaction.90 When a target DNA was introduced, 
capture probes on the chip and the probes on the AuNPs were ligated. 
Discrimination by the naked eye or flatbed scanner was executed after the silver 
enhancement and non-stringency wash. More recently, Gao et al. achieved real-
time PCR-like sensitivity and LOD in the detection of SNP by incorporating 
AuNPs in LCR.91, 92 A nicked duplex was first formed when the two types of 
AuNP-tagged capture probes were brought together by the target during 
hybridization at 45 °C. The two capture probes that were fully complementary 
to the target (template) can be covalently connected by ligation at the mutation 
site, whereas the other capture probes remained unaffected because of the 
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mismatch at the mutation site. The subsequent denature process separate the 
SNP target and the ligated strands, both of which served as templates for the 
next round LCR. Exponential amplification of the ligation product can be 
achieved and irreversible change of the color of the reaction mixture from wine 
red to grey can be detect to confirm the existence of the target DNA down to 20 
aM. Aside from AuNPs, AgNPs were also coupled to ligation-based technique 
for the SNP genotyping and quantification. Erickson and his co-workers utilized 
AgNPs as signal enhancers of SERS and by engaging ligase detection reaction 
(LDR), SNPs in human KRAS oncogene were successfully identified.93, 94  
 
Ordinary PCR utilizes primer pairs for extension and amplification of target 
genes.95 However, to detect the existence of SNPs, primers with single-base 
variations at the 3’ ends, deliberately designed at SNP sites, are engaged in an 
allele-specific PCR so that the extension reaction of PCR occurs with only 
perfectly matched sequences. The first successful application of SNP 
genotyping by the allele-specific PCR was realized by Gibbs et al.,96 in which 
a third primer (common primer) was introduced to identify the products with 
different “allele-specific primers”. A high discrimination factor of 100 proved 
the robustness and reliability of this technique. Another technique termed 
single-base extension (SBE) was firstly proposed by Anderson et al.97 Primers 
with their 3’ ends immediately adjacent to query sites of mutations were 
designed to hybridize to target DNA. An SBE reaction occurred with the 
introduction of four dideoxynucleotides tagged with distinctive reporting 
molecules,98 which can be detected by various techniques like fluorometry99 and 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
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(MALDI-TOF MS).100 Afterwards, Steemers et al. proposed a whole-genome 
genotyping technique using a two-color SBE reaction to score the SNPs on a 
BeadArray platform.101 Target DNA was hybridized with primers pre-
immobilized on the beads and SBE reaction processed subsequently. Based on 
the same concept, instead of polymeric beads, gold-coated magnetic NPs 
functionalized with streptavidin (SA-GMNPs) were used for the immobilization 
of the primers.102 After the SBE reaction, the GMNPs were loaded with 
fluorophore-tagged SBE products and the SNP genotyping can be accomplished 
by comparing the output color. The use of the GMNPs offers a very convenient 
means for separating the SBE products from the reaction mixture, thus 
alleviating the requirement for PCR-product purification and producing an 
ultralow background.  
 
Restriction endonucleases are a class of enzymes that specifically recognize and 
cleave certain DNA sequences.103 In contrast, they are unable to cleave their 
targets if their recognition regions contain SNPs or other types of mutations.104 
Leveraging on this property, SNPs within the recognition regions of the 
restriction endonucleases can be detected. Invader assay is a SNP genotyping 
technique using a restriction endonuclease towards the DNA triplex among a 
target DNA strand, an allele specific probe and an invader probe.105 If the allele 
specific probe perfectly matches the target DNA, the restriction endonuclease 
cleaves off the invader probe from the DNA triplex; while the triplex containing 
an imperfectly matched DNA strand, the invader probe in the triplex cannot be 
cleaved off. SNP genotyping is realized through the fluorescent tag on the 
released invader probe. Further to this concept, Hall and colleagues developed 
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an advanced version of the invader assay in which two invasive reactions were 
used for the amplification of the target DNA.106  Consequently, the 
amplification power of the invader assay was enhanced by three orders of 
magnitude, i.e. from 104 to 107. 
 
In order to achieve the desired sensitivity and LOD, the allele-specific 
enzymatic reaction-based techniques, for example LCR and invader assays, rely 
on enzymatic amplifications of the targets. Since these assays normally engage 
several enzymes (such as ligase and restriction nucleases) and signal generating 
tags (such as AuNPs and fluorophores) incorporated in the amplification 
products, it remains to be seen whether they are able to outperform PCR-based 
techniques in terms of speed, cost, LOD, sensitivity and specificity. 
 
1.4.2.3 Sequencing techniques  
The above mentioned two techniques are based on known SNPs (sequences) in 
order to specifically design the SNP probes with certain sequences to achieve 
the allele-specific discrimination, thus implying that these SNP genotyping and 
quantification techniques are not applicable for genotyping and quantification 
of new or unknown SNPs. In contrast, sequencing techniques are a group of 
powerful tools in the discovery of new SNPs. 
 
The gold standard of DNA sequencing is the Sanger sequencing technique, 
which is a chain-termination-based method. It was widely and almost 
exclusively adopted during the early stage of genomic research. The most 
successful application of Sanger sequencing technique is the Human Genome 
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Project, during which the first collection of SNPs was actually accomplished by 
Sanger sequencing. Unfortunately, the main drawbacks of this technique are its 
low throughput and formidable high cost, which hinder its further applications 
in diagnosis and prognosis in our everyday life.  
 
In order to overcome the drawbacks of the traditional Sanger sequencing 
technique, various next-generation sequencing (NGS) techniques sprang up 
around the world with the advent of microfabrication techniques. 
Representative NGS techniques that have been developed include 
pyrosequencing which is the first commercialized NGS technique,107 single 
molecule real-time (SMRT) sequencing,108 Illumina,109 supported 
oligonucleotide ligation and detection (SOLiD),110 and Ion Torrent which is the 
latest entry of the NGS family.111 These NGS techniques dramatically increased 
the throughput and offer the possibility to genotype unknown SNPs at large 
scales.112, 113 Further detailed discussion on this type of techniques can be found 
involved in a published review article114 and will not be given here because 
sequencing techniques for genotyping unknown SNPs is beyond the scope of 
this thesis. Nonetheless, this does not deny the significance of the NGS 
techniques. On the contrary, NGS techniques will provide the basis for 
developing SNP bioassays since it makes the unknown SNPs in DNA to be 
known and then let the other SNP genotyping and quantification techniques 
follow up. Thus, NGS techniques surely hold their irreplaceable positions in 
genomic research despite some of them are still expensive and time-consuming 
to some extent. The other two categories of techniques can be chosen once the 
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SNPs are identified by sequencing. In this way, it will be much more economic 
both in time and financial resources for SNP genotyping and quantification.  
 
1.4.3 Detection techniques developed in this thesis 
In Chapter 2 of the thesis, an allele-specific enzymatic technique for SNP 
genotyping and quantification is demonstrated. By employing nucleases for 
LCR amplification, the bioassay exhibited excellent sensitivity and selectivity 
for genotyping and quantification of the disease-related SNPs. 
 
1.5 Detection of abnormal expression levels of miRNAs 
1.5.1 Difficulties in the detection of miRNAs 
Precise discrimination and quantification of miRNA with a specific sequence 
that has high clinical relevance to disease is essential to human health. On one 
hand, it is necessary to investigate the regulatory functions of miRNAs and 
further the drug discovery. On the other hand, it is critical for early diagnosis, 
prognosis, and in-time therapy. Nonetheless, unlike DNA and message RNA 
(mRNA), the unique attributes of miRNAs, such as their short lengths, low 
abundance, and high sequence similarities among members of a miRNA family, 
make miRNA detection with high sensitivity and specificity technically 
challenging and demanding.115  
 
The short lengths of target miRNAs bring difficulty to the hybridization-based 
detection since the melting temperature of the duplex formed between a probe 
and a target miRNA is low, which reduces the stringency of hybridization and 
is more prone to induce imperfect match and subsequently a false response. 
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Moreover, the short lengths of miRNAs will also obstruct the using of general 
PCR-based assays since the primers in PCR have similar sizes with miRNAs. 
In order to carry out the PCR-based assays, much shorter primers are desired. 
However, shorter primers have quite low melting temperatures and low 
specificity, which will severely affect the efficiency and specificity of PCR as 
well as the assay.116  
 
The concern of low abundance of miRNAs demands that the detection 
techniques of miRNAs should be able to obtain low background signals (high 
S/N ratios), high sensitivity and low LOD; otherwise a minute amount of target 
miRNA cannot be assuredly identified and quantified.  
 
As for the issue of high sequence similarities among miRNA family members, 
it needs to be addressed by designing and fabricating assays with high 
selectivity so that different miRNAs with down to one-base difference can be 
undoubtedly distinguished.  
 
1.5.2 Developed techniques for miRNA detection 
Up to the present moment, various classical techniques for miRNA detection 
including Northern Blotting and quantitative reverse transcription PCR (qRT-
PCR), as well as recently emerged techniques including PCR-free molecular 
biology-based techniques and nanotechnology-based techniques have been 




1.5.2.1 Classical techniques for miRNA detection 
Northern blotting was developed by Alwine and colleagues in 1977 at Stanford 
University.118 It employs electrophoresis to separate RNA by size, and then 
transfer the separated RNA to a membrane (the actual northern blotting step), 
followed by the hybridization with detection probes and final detection. 
Northern blotting was the primary choice for the investigation of miRNAs 
during the early days.119, 120 It was widely adopted because it is suitable to detect 
miRNAs with different sizes121, 122 and has provided significant values in studies 
that how miRNAs play crucial roles in the gene regulation. However, the 
laborious procedure, time-consuming approach, large sample-amount demand, 
toxic chemical involvement, low throughput, and inferior sensitivity of 
Northern blotting motivated scientists to explore better alternatives.123-125  
 
 
Figure 1-3. Unique reverse transcription strategies for miRNA to generate 
cDNA. (Reprinted with permission from reference 123. Copyright 2013 
American Chemical Society)  
 
As the gold standard for profiling gene expression, qRT-PCR is commonly used 
for the detection of abnormal expressed disease-related miRNAs. The reverse 
transcription refers to transcribing RNA to its complementary DNA (cDNA), 
which then undergoes the general PCR procedure. As mentioned above, 
miRNAs are so short that it is difficult to find proper primers and then go 
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through the reverse transcription. Thus, as can be seen from Figure 1-3, unique 
reverse transcription methodologies,115, 123, 126 including the widely used 
poly(A) polymerase extension method, and stem-loop primer/liner specific 
primer extension method are used to successfully generate a cDNA with proper 
length for the subsequent PCR. The qRT-PCR techniques involving TaqMan 
probes or SYBR green as signal generators have achieved excellent 
performance, and corresponding assays have already been commercialized. 
Nonetheless, qRT-PCR is even more complicated than the ordinary PCR. It is 
more expensive, time-consuming and labor-intensive, and technically 
demanding since specialists with professional knowledge and skills are 
necessary. Besides, the whole process needs to be operated cautiously 
considering that any minor contamination may lead to large variations after the 
PCR amplification.  
 
1.5.2.2 Recently emerged techniques for miRNA detection 
Due to the limitations of the existing classical techniques mentioned above, and 
meanwhile the urgent demand of establishing high-performance bioassays to 
profile disease-related miRNA expression, several novel techniques such as 
PCR-free molecular biology methodology and advanced nanotechnology have 
been introduced to miRNA bioassays.  
 
In recent years, PCR-free molecular biology methodologies like LCR, 127, 128 
rolling circle amplification (RCA), 129, 130 hybridization chain reaction (HCR), 
131, 132 and duplex-specific nuclease (DSN)-cleavage reaction133, 134 have not 
been successively developed. The common property among these 
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methodologies is the signal amplification ability which is realized by target 
reusing and recycling, so that good sensitivity and low LOD can be achieved.  
 
For example, Zhang et al. described a sensitive and specific method to quantify 
multiple miRNAs simultaneously by using ligation and LCR techniques 
together. The ligation of DNA probes were first completed in the presence of 
target miRNAs (templates), and subsequently the ligated DNA sequences 
instead of target miRNAs underwent LCR for the signal amplification. 
Electrophoresis was used for the final detection and the LOD was pushed down 
to 0.2 fM.128 The thermal technique LCR can achieve outstanding sensitivity 
and selectivity as well as ultralow LOD and it has already gotten one step closer 
to point-of-care since it is much simplified compared with PCR. Nevertheless, 
the main drawback of LCR is the need of a thermal cycler which is not preferred 
at point-of-care. 
 
HCR is an enzyme-free and isothermal technique that can circumvent the 
thermal cycler. Yang et al. developed a graphene oxide (GO)-based fluorescent 
bioassay for sensitive detection of miRNA coupled with HCR.131 In the 
presence of a target miRNA, HCR was initiated and two species of fluorescent 
hairpin probes were triggered to form DNA duplex products. All the original 
probes and final products were then anchored on GO and only the fluorescence 
of the upright stood DNA duplexes were quenched by GO and thus their 
fluorescence was detected. The HCR-based miRNA bioassays are cost-effective 
and can achieve a good sensitivity as well as low LOD, but the selectivity is not 




Recently, Yin et al. engaged a DSN cleavage-based technique coupled with 
Taqman probes to sensitively and selectively detect miRNAs.133 The Taqman 
probes were cleaved by DSN when strands of a target miRNA perfectly 
hybridized to the probes, and the previously quenched fluorophores were then 
released and emitted a detectable fluorescent signal. Compared with LCR, DSN 
cleavage reaction is more attractive since it is isothermal and completely 
removes the requirement of a thermal cycler, but still can realize the target 
recycling and signal amplification. And compared with HCR, it employs the 
enzyme DSN that possesses excellent sequence-distinguish ability and thus can 
acquire superior selectivity. Therefore, DSN cleavage-based techniques has a 
good prospect regarding disease-related miRNA detection. 
 
During the past two decades, nanotechnology has gained significant progress 
and numerous nanomaterials are prepared for scientific research and 
applications. Nanomaterials, especially the zero dimensional nanoparticles and 
one dimensional nanowires, exhibited attractive properties for uses in miRNA 
bioassays. Firstly, due to their nanosize comparable to nucleic acids, 
nanomaterials can be engaged to miRNA detection in multiple ways, for 
example acting as the probe carrier, tag, catalyst, signal generator, or quencher; 
and ensure an even interaction with the miRNA. Secondly, the small dimension 
also minimizes the whole size of the bioassay, which is beneficial to the 
development of miRNA bioassays for uses at point-of care. Thirdly, different 
nanomaterials have their own specific properties that can be utilized and thus 
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widen the scope for developing various nanotechnology-based miRNA 
detection techniques.  
 
For example, AuNPs have many attractive properties such as good water 
dispensability, biocompatibility, catalytic ability, and an ultrahigh extinction 
coefficient (108–109 M-1cm-1). A real-time colorimetric bioassay for the 
detection of miRNA was established by making use the ultrahigh extinction 
coefficient of the AuNPs.135 AuNP networks were first fabricated and the 
presence of a target miRNA released the AuNPs and generated a colorimetric 
signal. Ruthenium oxide nanoparticles (RuO2 NPs) were found to have good 
peroxidase-like activity and thus can be used as an enzyme mimic for signal 
generation and amplification in the detection of miRNA. Peng et al. used RuO2 
NPs to tag miRNA as well as the enzymatic property to catalyze the 
polymerization of 3,3’-dimethoxybenzidine in order to achieve the amplified 
electrochemical detection of disease-related miRNAs.41  Other nanoparticles 
like quantum dots (QDs)136 and carbon nanoparticles137 were also  utilized to 
fabricate bioassays for miRNA detection. 
 
Proton doped PANI has a metal-like electronic conductivity and was thus 
involved in electrochemical bioassays for miRNA. For instance, Fan et al. 
demonstrated a nanogap-based technique for miRNA detection by employing 
electron-conductive PANI nanowires. After hybridization to capture probes, the 
target miRNA guided the deposition of PANI nanowires and thus signal 
amplification as well as the signal output were achieved. The conductivity of 
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the deposited PANI was then used to indicate the amount of target miRNA in a 
sample solution.138  
 
1.5.3 Detection techniques developed in this thesis 
In Chapter 3, one of the PCR-free molecular biology methodologies – DSN 
cleavage-based technique – is presented for the detection of target miRNAs. 
The engagement of DSN successfully realized target recycling and thus signal 
amplification, and meanwhile achieved the discrimination of target miRNA 
with specific sequence.  
 
In Chapter 4 and 5, a nanotechnology-based technique is demonstrated for the 
sensitive detection of miRNA. In Chapter 4, polymer nanowires were first 
synthesized in aqueous solution through a novel, simple and green method. This 
new synthetic method was then employed in Chapter 5 as the signal generating 
process and signal amplifier of the bioassay for disease-related miRNA.  
 
1.6 Purpose, significance and scope of this thesis 
The purpose of the studies reported in this thesis is to overcome the 
disadvantages of current bioassays and to develop novel, simple, cost-effective, 
highly sensitive, and selective bioassays for the detection of disease-related 
nucleic acids.  
 Considering the relatively inferior sensitivity and LOD of colorimetric 
bioassays, a novel colorimetric bioassay for the detection of DNA with high 
sensitivity and selectivity is established by coupling with advanced 
nanomaterials. In Chapter 2, a very cost-effective nanomaterial − ferrofluidic 
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nanoparticles which are made of iron oxide − will be introduced to bioassays 
for the genotyping and quantification of disease-related SNPs in DNA. 
 Regarding the complicated procedures and high cost of fluorescent 
bioassays, a simple fluorescent bioassay evading PCR amplification procedure 
for the detection of miRNA without losing good sensitivity is designed. In 
Chapter 3, an enzyme-based isothermal signal amplification method could be 
exploited instead of the tedious PCR and a much simplified fluorescent bioassay 
for the detection of disease-related miRNA is explored. 
 Bearing in mind that the impedimetric bioassays always can achieve 
excellent sensitivity and low LOD but are somewhat poor in repeatability, in 
Chapter 4 and 5, a highly sensitive and reproducible impedimetric miRNA 
bioassay on the basis of target-guided deposition of an insulating polymer is 
developed for the disease-related miRNA profiling.  
 
By overcoming the weaknesses and making full use of the strength of the 
existing bioassays, newly developed bioassays extend the application range of 
each method. They also open new perspectives in developing nucleic acid 
detection tools for diagnosis and prognosis of genetic diseases. Once the 
genotyping and profiling platform for disease-related nucleic acids is applied to 
clinical practice, timely prevention and early treatment can thus be carried out 
and the mortality rate of patients will be reduced. 
The studies in this thesis focus on establishing two new optical bioassays and 
one electrochemical bioassay since these two types of bioassays are among the 
most promising bioassays for the detection of disease-related nucleic acids. The 
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Chapter 2. A Ferrofluid-Based Homogeneous Bioassay for Highly Sensitive 









Nucleic acids provide the genomic templates1 that encode for proteins essential 
for all cellular functions. Ample evidence has revealed that diseases like cancer 
are closely associated with mutations in gene sequences and single-nucleotide 
polymorphisms (SNPs) in particular.4 The importance of SNPs has urged 
researchers to develop SNP detection methods for their sensitive and accurate 
identification in the presence of excessive wild-type (WT) genes. By knowing 
these SNPs, population screening and disease diagnosis can be designed and 
performed accordingly. Therefore, SNPs have become an important class of 
biomarkers in diagnosis after the completion of the Human Genome Project. 
Unlike other DNA assays, the intrinsically subtle difference between WT and 
mutant genes – a single base variation – makes it a challenging task to 
specifically detect low abundant SNPs out of large amounts of co-existing WT 
genes. Conventional techniques for SNP detections rely mostly on polymerase 
chain reaction (PCR) and fluorescence detection. Unfortunately, this technique 
is highly time-consuming and cost intensive as the fluorescence readout requires 
expensive instrumentation and sophisticated algorithms.62 Owing to the desire 
for SNP detection devices with high specificity, high sensitivity, low LOD and 
low-cost operation, enormous efforts have been invested in research to improve 
analytical performance of SNP assays.  
 
With the advancement in nanotechnology over the past decade, materials with 
dimensions in scale of 1 to 100 nm are playing a significant role in the 
development of SNP assays.139 With unique size-dependent physical and 
chemical properties such as high surface-to-volume, high surface energy, 
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surface plasmon resonance, and quantum effect, nanoparticles allow stable 
immobilization of bioreceptors and being coupled to many new signal 
transduction and amplification schemes.140, 141 To date, many heterogeneous 
SNP screening assays using nanoparticles in conjunction with colorimetry, 
fluorometry or electrochemical methods have been proposed.142 Heterogeneous 
detection, however, has low hybridization efficiency due to steric hindrance and 
limited number of probes coated on the solid support further restricts the 
performance of the assays.142 To realize SNP assays that offer the simplicity of 
the heterogeneous approach along with high hybridization efficiency and 
reproducibility of homogeneous assay, magnetic nanoparticles (MNPs) were 
used to facilitate homogeneous hybridization and provide simple and quick 
separation of the hybridized products.143 With appropriate surface coating, 
MNPs can be solubilized in water and provide functional moieties for 
bioreceptors attachment to design the capture and/or detection probes. Spatial 
hybridization between probes and target can also be achieved with the reaction 
being performed in a homogeneous manner. The ease of magnetic separation is 
frequently used to overcome the shortcoming of homogeneous ligation by 
removing reacted probes from unreacted ones which would otherwise pose as a 
threat to the detection.143  
 
In view of the urgent need for simple and inexpensive SNP assays, this report 
presented a novel SNP assay that for the first time exploited the intrinsic 
properties of ferrofluid (colloidal MNPs). Efficient homogeneous hybridization 
was carried out by oligonucleotide-coated ferrofluidic nanoparticle probes 
(FNPs). The amplification power of the assay was demonstrated by the 
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incorporation of a ligase chain reaction (LCR) in which a minute amount of 
target crosslink millions the FNPs together forming an aggregate of the FNPs. 
Separation of the reacted (aggregate) from the unreacted (free) FNPs was 
achieved simply based on their drastic difference in magnetic field strength 
under an external magnetic field. Finally, SNP is conveniently genotyped and 
quantified by colorimetry. 
 
2.2 Materials and methods  
2.2.1 Reagents and apparatus 
Unless otherwise stated, reagents were obtained from Sigma-Aldrich (St Louis, 
MO, USA) and used without further purification. 1-Ethyl-3-3-
dimethylaminopropyl carbodiimide hydrochloride (EDC) and N-
hydroxysuccinimide (NHS) were acquired from Pierce (Rockford, IL, USA). 
Diethylene glycol (DEG) and tris (hydroxymethyl) aminomethane (Tris) were 
from Alfa Aesar (Heysham, UK). Ampligase® thermal stable ligase kit was 
brought from Epicenter Biotechnologies (Madison, WI, USA). Hydrogen 
peroxide (QRec, 30–32%, AR) was obtained from ERC Sdn Bhd (Malaysia). 
Dimethyl sulfoxide (DMSO) was gotten from MP Biomedicals LLC (Solon, 
OH, USA). H3PO4 (85%) was provided by Fisher Scientific PTE LTD 
(Singapore). HCl (37%) was bought from Schedelco Pte Ltd (Singapore). 
NaOH (Chemi-con, 99–100%) was from Dickson Instrument & Reagent Store 
(Singapore). Unmodified oligonucleotides were custom made by 1st Base 
(Singapore) and the modified oligonucleotides were custom made by Integrated 
DNA Technologies Incorporated (Coralville, IA, USA). All the reagents were 
without further treatment unless specified. All aqueous solutions were freshly 
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prepared with nuclease-free ultrapure (UP) water with an electrical resistance 
of 18.3 MΩ·cm. The pH of the Phosphate buffered saline (PBS) was adjusted 
by adding an appropriate amount of NaOH solution or HCl solution.  
 
UV-Vis absorption measurements were carried out using an Agilent Cary 60 
UV-Vis spectrophotometer which was from Agilent Technologies Singapore 
PRE LTD (Singapore). Fourier transforms infrared (FT-IR) spectroscopic 
experiments were performed with a Bio-Rad Excalibur Series FTS 3000 
spectrometer (Hercules, CA, USA) using KBr pallets and the spectra were 
collected after 20 scans between 4000‒400 cm-1 at a resolution of 4 cm-1 for 
characterization of poly acrylic acid (PAA) coated MNPs. Transmission 
electron microscope (TEM) was conducted on FEI Tecnai F20 which is 
provided by FEI Company (Hillsboro, OR, USA) using a 200kV acceleration. 
Thermogravimetric analysis (TGA) was performed on SDT-2690 Simultaneous 
DTA-TGA which is provided by TA Instruments (New Castle, DE, USA) from 
room temperature to 800 ºС with a heating rate of 10 ºС /min under air 
atmosphere.  
 
2.2.2 Preparation of ferrofluidic MNP-PAA 
The magnetic nanoparticles coated with poly acrylic acid (MNP-PAA) were 
synthesized following the protocol by Ge et al.144 with slight modifications to 
control the particle size. The NaOH/DEG stock solution was prepared by 
dissolving 50 mmol NaOH in 10 mL DEG at 120 °C for 1 hr under argon before 
cooling down and then kept at 70 °C. In the synthesis, 2 mmol FeCl3 was first 
dissolved in 8 mL DEG before adding 4 mmol PAA. The mixture was heated to 
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220 °C under argon and vigorous stirred for 30 min until a transparent light-
yellow solution was obtained. A 1 mL of NaOH/DEG stock solution was then 
injected rapidly into the above hot mixture and heated for another 10 min to 
induce the formation of black solution containing MNP-PAA with desired size. 
The final product was washed with repeating precipitation with ethanol and re-
dispersion in UP water for three times, and finally dispersed in 1 mL UP water 
for further use. 
 
2.2.3 Prepare ferrofluidic nanoparticle probes 
The FNPs were prepared by functionalizing colloidal MNP-PAA with the 
amine-terminated oligonucleotide 1 and 2 (in Table 2-1), respectively. 
Carboxyl-terminated MNP-PAA were pretreated in 10 mL of 10 mM PBS (0.5 
M NaCl, pH 5.5) containing fresh-prepared 3 mM EDC and 5 mM NHS for 1 
hr at room temperature. The suspension was then washed three times with PBS 
buffer to remove the excess reagents before addition of the oligonucleotides. 
After gently shook at room temperature for 3 hrs, the oligonucleotide-attached 
MNPs were obtained by centrifugation and the probe content was analyzed. 
Generally, there were 20 oligonucleotides strands on the surface of each FNP. 
The unreacted carboxyl groups on the MNP were blocked by incubating with 1 
M glycine for 2 hrs. After thorough washing with PBS buffer, the FNPs were 
kept at 4 °C and ready for use. 
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Table 2-1. Synthetic oligonucleotides (5'→3') used in the bioassay 
Name Sequence 
Oligonucleotide 1 NH2-TTT TTT TTT TT GCC TAC GCC AC-OH 
Oligonucleotide 2 PO4-G AGC TCC AAC TAC CA TTT TTT 
TTT-NH2 
MT-C Half Target A TG GTA GTT GGA GCT C 
MT-C Half Target B PO4-GT GGC GTA GGC AA 
KRAS Wild-Type Target 
(KRAS WT) 
AAA CTT GTG GTA GTT GGA GCT G|GT 
GGC GTA GGC AAG AGT GCC TTG 
KRAS Mutant Target-C 
(KRAS MT-C) 
AAA CTT GTG GTA GTT GGA GCT C|GT 
GGC GTA GGC AAG AGT GCC TTG 
 
2.2.4 Buffer optimization for hybridization   
Presence of cations and pH in the buffer would affect the stability of FNPs and 
the hybridization efficiency with target DNA. To determine the stability of the 
FNPs, the 90 nM FNP-1 and 90 nM FNP-2 and 15 nM KRAS MT-C target were 
dispersed into a series of 1.6 mL 50 mM tris-HCl buffers varying the sodium 
(Na+) salt concentrations (50 mM, 500 mM, 1000 mM, 1500 mM and 2000 mM) 
and pH values (5.5, 6.5, 7.5, 8.5 and 9.5). The UV-Vis absorbance of the 
unbound FNPs was observed at 260 nm before and after magnetic separation. 
To determine the hybridization efficiency, the FNPs were incubated with the 
totally complementary template, KRAS MT-C target, in the same series of 
buffer at room temperature for 1.5 hrs. Similarly, the UV-Vis absorbance of 
unbound FNPs was observed at 260 nm before and after magnetic separation. 
 
2.2.5 TMB-based signal amplification  
After separating out the hybridized FNPs by permanent magnet, a colorimetric 
detection was performed subsequently on the unbound FNPs following the 
protocol by Gao et al.145 The assay was carried out at room temperature in 1 mL 
of reaction buffer (0.2 M HAc/NaAc, pH 3.5) containing 530 mM hydrogen 
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peroxide, 81.6 μM TMB and 40 μL of the remaining unbound FNPs. The 
reactions were allowed to incubate at room temperature for 1 hr before 
recording the UV-Vis absorbance of product at 652 nm.  
 
2.2.6 Ligation chain reaction 
To further improve the sensitivity and push down the LOD of assay, ligation 
chain reaction (LCR) was employed to amplify the signal as previous report.143 
Ampligase® thermal stable ligase was used to facilitate the exponential 
amplification in the LCR. In a typical reaction, a 100 μl of reaction solution 
containing 1 ×  Ampligase reaction buffer, 50 U Ampligase, 1.5 μM FNP-1, 1.5 
μM FNP-2, 1.5 μM MT-C target half A, 1.5 μM MT-C target half B, and KRAS 
MT-C target was subjected to 15 thermal cycles of LCR. Each thermal cycle 
composed a 2-min ligation at 45 °C and a 1-min denaturation at 90°C. After the 
thermal cycling, the ligated FNPs was dispersed in 900 μL of the optimized 
hybridization buffer and separated by the magnet. Subsequently, TMB-based 
signal amplification was performed on the unbound FNPs to determine the 
original target. The calibration curve was depicted accordingly.  
 
2.3 Results and discussion 
2.3.1 Principle of the assay 
 
As illustrated in Figure 2-1, the SNP assay comprises of three steps:  
(i) capturing of target SNP strands via hybridization and LCR with the 
FNPs to form a FNP aggregate 
(ii) magnetic separation of the FNP aggregate from unreacted FNPs  
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(iii) amplified colorimetric detection of the unreacted FNPs  through the 
catalytic oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) by the 
FNPs.145  
 
Figure 2-1. Schematic of (a) the working principle the ferrofluid-based 
homogeneous assay for SNP (b) sequences of the FNPs and target DNA.  
 
Highly water-soluble FNPs were prepared and discretely functionalized with 
the two types of amine-terminated oligonucleotides (FNP-1 and FNP-2) via 
amide coupling reaction with the carboxylic groups of PAA that encapsulated 
the FNPs. The FNP-1 will align with FNP-2 when both of them are annealed 
onto a target SNP template i.e. KRAS, a mutation (MT-C) as depicted in Figure 
2-1. Amplification is attained by the LCR in which multiple hybridizations 
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occur among the FNPs with minute amount of the target to form the FNP 
aggregate. Under an external magnetic field, each FNP will act as single 
magnetic domain and when numerous FNPs aggregated during hybridization, 
the large FNP aggregate behaves much more strongly towards the magnetic 
field. Separation of the FNP aggregate from the unreacted FNPs is achieved by 
using a permanent magnet to pull and pack the FNP aggregate to the bottom of 
the reaction vessel. 
 
To ensure the success of assay, it is crucial that there a substantial difference 
between individual FNPs and the FNP aggregate so that the unreacted FNPs 
stay in the reaction mixture when a magnetic field is applied through a 
permanent magnet. In other words, the FNP aggregate should set out easily in a 
magnetic field whereas the free FNPs remain in solution. It is well-known that 
when MNPs are sufficiently small ( 10 nm) and each MNP is thoroughly 
covered with an anti-clumping coating, the magnetic attraction of MNPs is weak 
enough that the Van der Waals force of the anti-clumping coating is sufficient 
to prevent magnetic clumping or agglomeration – forming a ferrofluid.146 It was 
reported that poly acrylic acid (PAA) coated MNPs (6–8 nm) show ferrofluidic 
behavior when the colloidal solution of the PAA coated MNPs is subjected to 
an external magnetic field, due to their small size and superparamagnetic 
properties.144 Therefore, the PAA coated MNPs were employed in this work. 
Two types of the FNPs (FNP-1 and FNP-2) were prepared by functionalizing 





Figure 2-2. TEM image of the highly water soluble MNP-PAA prepared. The 
magnetic nanoparticles were synthesized with a particle diameter around 6–8 
nm.  
 
As shown in Figure 2-2, TEM image showed that the diameter of MNP-PAA is 
around 6–8 nm. To verify the MNP-PAA prepared, other characterizations 
including TGA and FT-IR were also carried out. TGA curve in Figure 2-3 
indicated that the main weight loss is around 300 ºС and 320 ºС, which should 
be due to the dehydration and decarboxylation of PAA. The weight ratio of the 
MNPs is about 58% and PAA is about 38%. The FT-IR spectrum in Figure 2-4 
confirmed the existence of PAA on MNPs. Strong band at 588 cm-1 belongs to 
the Fe-O vibration of the MNPs. Three peaks located at 1404, 1455 and 1526 
cm-1 were assigned to symmetric C-O stretching of -COO- groups, asymmetric 




Figure 2-3. TGA curve of the highly water soluble MNP-PAA prepared.  
 
 
Figure 2-4. FT-IR spectrum of the highly water soluble MNP-PAA prepared.  
 
Moreover, functionalization of the MNPs with anionic oligonucleotides further 
stabilized the MNPs, forming a very stable ferrofluid (Figure 2-5 inset). Apart 
from the formation of ferrofluid, another critical factor is the functionality of 
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the FNPs. The FNPs must be freely accessible to both the SNP target and ligase, 
and particularly to the ligase as it is much bulkier than the SNP target. As can 
be seen in Figure 2-1(b), the two amine-terminated capture probes were 
therefore designed with a (T)9 spacer to eliminate any possible steric effect. 
Furthermore, surface densities of the probes were kept low by controlling the 
concentrations of the oligonucleotide probes. It was estimated that on average 
20 oligonucleotide probes were attached onto each FNP. 
 
 
Figure 2-5. UV-Vis spectra of TMB solution treated by 10 nM MNPs after 
hybridizing with (1) control, (2) 2.0 and (3) 6.0 nM SNP target. Inset: 
Photographs of the FNP in the solution without/with applying a permanent 
magnet. 
 
To demonstrate the accessibility of the immobilized probes on the FNPs, a 
complementary KRAS MT-C target and a control were introduced to the FNPs, 
respectively. As revealed in Figure 2-5, the control showed practically identical 
UV-Vis responses before and after hybridization and magnetic separation, thus 
suggesting that there is no FNP aggregate formation and the free FNPs remain 
in solution even subjected to the permanent magnet. This is evidently due to 
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their ultra-small size and high dispensability after functionalization.144 On the 
other hand, after hybridization with the KRAS MT-C target, a significant 
change in absorbance was observed after magnetic separation, indicating that a 
large amount of FNPs was removed by the magnet. The results suggest that the 
functionalized FNPs are capable of capturing the SNP target and hybridizing 
into a FNP aggregate that can be separated out by the permanent magnet. 
 
2.3.2 Optimization of the conditions 
To achieve highest possible analytical signal, there should be efficient 
hybridization of FNPs with the SNP target to form the FNP aggregate that will 
be first set out by the permanent magnet and leaving the unreacted FNPs in the 
solution. One key factor that greatly influences the hybridization efficiency is 
the presence of cations. In general, cations are added into the hybridization 
buffer to compensate for the negatively-charged phosphate groups on the 
oligonucleotide backbone and stabilize the hybridized duplexes.147 However, an 
increase in ionic strength of the buffer often leads to colloid coagulation (self-
aggregation) as the double layer thickness decreases. Self-aggregation of the 
FNPs would pose a threat in distinguishing the unreacted (free) and hybridized 
(aggregate) FNPs. Furthermore, pH-induced conformational changes in the 
oligonucleotide probes may hinder the accessibility and binding affinity of 
target to the immobilized probes.148 Optimization of the hybridization buffer is, 
therefore, a critical step to establish good stability of the FNPs and at the same 




Figure 2-6. Buffer optimization: effect of monovalent cation (Na+) 
concentration ranging from 50 mM to 2.0 M on the stability and hybridization 
efficiency of the FNPs. Curve marked with 2 is the sample and curve marked 
with 1 is the control. 
 
In this work, tris-based buffers were used to ensure that the hybridization 
process will be solely influenced by the free cations coming from the added salts. 
Monovalent salts were found to be much more efficient in duplex stabilization 
in solution than divalent salts.147 Thus, the cationic shielding effect influencing 
the stability and hybridization efficiency of the FNPs was studied with 
concentration of the monovalent sodium in range of 50 mM to 2 M (Figure 2-
6). The negligible change in absorbance for FNPs in the absence of the SNP 
target (trace 1) showed relatively good stability of the FNPs in the buffer. A 
slight increase in A observed when sodium concentration increased above 1 
M suggest that coagulation of the FNPs occurs due to the decrease in 
electrostatic repulsion between FNPs as ionic strength of buffer was further 
increased. Fortunately, such effect did not obstruct the hybridization process. 
The change in absorbance for the FNPs after reacting with the SNP target was 
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significantly larger than that of the control (trace 2). This indicates that the FNPs 
have hybridized with the SNP target to form the FNP aggregate which is then 
separated out quickly from the solution by the magnet. Thus, the amount of free 
FNPs in solution decreases substantially and leads to the significant change in 
absorbance. It was also observed that the hybridization efficiency increases with 
increasing concentration of sodium, a trend found in several other DNA sensing 
systems.149, 150 On the other hand, a reverse effect started to show when the salt 
concentration was increased beyond 1 M. Again, this could be due to the 
decrease in electrostatic repulsion, causing the FNPs to aggregate and hinder 
the hybridization process. Nonetheless, the hybridization was shown to be most 
efficient at 1 M of sodium concentration.  
 
The accessibility and binding affinity of target to the FNPs were studied in 1 M 
of sodium buffers varying in pH range from 5.5 to 9.5 (Figure 2-7). The FNPs 
remained considerably stable in the pH range studied (trace 1) while the 
hybridization process was significantly affected by the acidity of the 
hybridization buffer (trace 2). The largest response was observed at pH 7.5, thus 
implying that there is minimal steric hindrance between neighboring FNPs and 
the hybridization process was most efficient. At lower pH, protonation of the 
base groups on phosphate backbone decreases electrostatic repulsion between 
the FNPs and hindered the hybridization processes. Similarly, low hybridization 
efficiency observed at higher pH could be due to extensive deprotonation of the 
base such that the probes bend away from each other. Therefore, the optimal 
conditions that allow efficient hybridization and differentiation of the 
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hybridized FNP aggregate from the unreacted FNPs were 1 M of sodium at pH 
7.5. 
 
Figure 2-7. Buffer optimization: effect of pH ranging from 5.5 to 9.5 on the 
stability and hybridization efficiency of the FNPs. Curve marked with 2 is the 
sample and curve marked with 1 is the control. 
 
2.3.3 LOD of the assay 
With this distinct change associated with the SNP target and the catalytic 
properties of the FNPs toward the oxidation of TMB,145 additional experiments 
were conducted to establish the relationship between the colorimetric signal and 
the target concentration. It was found that the FNPs can be directly utilized for 
the detection of SNPs in the range of 1.0 to 90 nM. However, such an LOD is 
far below the requirement for SNP detection and an in situ amplification 
mechanism is therefore inevitable to make this assay more appealing. 
 
To improve the assay sensitivity and obtain a lower LOD, the minute amount 
of target captured by the FNPs has to be amplified and this could be fulfilled by 
performing PCR before hybridization. However, the cost and time consumed 
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would gradually increase for such multiple-steps assay despite the exceptional 
amplifying power of PCR. An alternative way is to employ LCR. This allele-
specific enzymatic ligation provides similar amplification power as PCR and is 
able to amplify the target and ligate the MNP probes simultaneously under 
specific thermal cycling conditions.93, 143 More importantly, through judicious 
design of the two probes with SNPs located at the ligation sites, LCR is much 
more specific than PCR for SNPs genotyping.91 To significantly improve the 
sensitivity and decrease the LOD of the assay, LCR was therefore utilized to 





Figure 2-8. Calibration curves (●) for the response of unbound probe-catalyzed 
colorimetric TMB oxidation in the presence of target KRAS MT-C after LCR 
(15-thermal cycles). Femtomolar samples are marked with (). Error bars stand 





Figure 2-9. UV-Vis absorbance spectra of the unbound probe-catalyzed 
colorimetric TMB oxidation when 0, 3, 8 16, 25 and 35 pM SNP target present 
in the assay. 
 
As can be seen in Figure 2-8, a calibration curves for the response of unbound 
probe-catalyzed colorimetric TMB oxidation in the presence of target KRAS 
MT-C after 15-thermal cycles LCR was depicted with a dynamic range from 0 
to 35 pM. A linear coefficient 0.99 validated that this assay is reliable for SNP 
discrimination. The corresponding UV-Vis absorbance spectra of each point on 
the calibration curve were shown in Figure 2-9, and the assay was shown to be 
able to distinguish the SNP target at concentration as low as 3 pM after only 15 
thermal cycles. This LOD was three orders of magnitude lower than that without 
target amplification and comparable with the best colorimetric SNP assays. 
Moreover, femtomolars of SNP targets were detected when extensive thermal 
cycling (up to 20 thermal cycles) was performed. As indicated in Figure 2-8, 
two red points in the calibration curve referred to that the concentrations of 
targets was 300 fM and 600 fM before LCR, and after 5 thermal cycles of LCR, 
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the concentrations of the targets were theoretically increased to 9.6 pM and 19.2 
pM respectively. Thereafter, they were subjected to the same experimental 
procedure as the samples for calibration curve above-mentioned. Since it was 
found that the final signals detected can be fit to the calibration curve, the 
femtomolar LOD was regarded as achieved. 
 
2.3.4 SNP discrimination of the assay 
Figure 2-10. SNP discrimination of the assay with large excess mismatch 
sequences. Comparing to the control set (MT-to-WT = 1:0), no significant 
change in signal was observed even when the WT concentration was 1000 times 
higher. Similarly, SNP detection was carried out with KRAS mutation-to-wild 
type target (MT-to-WT) ratios up to 1:1000. 15.6 pM MT-C target was used. 
 
 
The capability of the FNPs to discriminate mutants is particularly important in 
SNP genotyping. To determine the ability of selectively detecting the SNP 
target in sample matrix containing large excess mismatch sequences, SNP 
detection was carried out with KRAS mutation-to-wild type target (MT-to-WT) 
ratios ranging from 1:0 to 1:1000. Comparing to the control set (MT-to-WT = 
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1:0), no significant change in signal was observed even when the WT 
concentration was 1000 times higher (Figure 2-10). This implies that the 
nonspecific binding of mismatch sequence to the FNPs is negligible. The 
excellence analytical performance of this assay strongly supports that the 
specific-designed FNPs are highly sensitive and selective in the screening for 
SNP target even in complex matrixes.  
 
Table 2-2. Comparison of several literature methods for SNP detection 
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The proposed bioassay here for SNP genotyping and quantification was also 
compared with its counterparts reported previously. As summarized in Table 2-
2, compared to the previously published SNP discrimination method, the 
present work exhibited its advantageous LOD as well as SNP discrimination 
ability.   
 
2.4 Conclusion 
In conclusion, the proposed assay revealed the versatility and power of FNPs as 
the target capturer and signal generator for SNP genotyping and quantification. 
The assay was able to discriminate one copy of the SNP target in 1000 copies 
of WT gene. The demonstrated attractive characteristics of simple, rapid and 
low cost colorimetric SNP genotyping could therefore open a new perspective 
in the development of SNP genotyping tools for uses at point-of-care. Ongoing 
efforts may apply this assay to screen for SNPs in real samples and expand its 

























MicroRNAs are highly conserved17 small RNAs that regulate the expression of 
genes by binding to the 3’-untranslated regions of messenger RNAs (mRNAs) 
through a dual-mechanism: translational repression and target degradation.3, 153 
A representative family of miRNAs is the lethal-7 (let-7), the first known human 
miRNA family that has ten mature sequences in humans, i.e. let-7a, 7b, 7c, 7d, 
7e, 7f, 7g, 7i, mir98 and mir202.154 They were discovered for the first time in 
the nematode as crucial developmental regulators.155 It has been observed that 
numerous diseases such as various types of cancer like lung cancer and breast 
cancer, metabolic syndromes like diabetes,10 are closely associated with 
abnormal expression levels of miRNAs. Increasing evidence has suggested that 
miRNAs are potentially diagnostic as well as prognostic biomarkers. For 
example, several studies have indicated that the expression levels of let-7 
miRNAs are frequently lower in tumor tissues than those in normal tissues.156 
Removal of let-7 binding site on mRNA causes over expression of protein and 
produce tumor157 since let-7 miRNAs acting as tumor suppressors can no longer 
function. As for the metabolic syndromes, an essential role of let-7 family plays 
is that it regulates glucose metabolism in multiple organs. Over expression of 
let-7 in pancreas will lead to impaired glucose tolerance and reduced pancreatic 
insulin secretion, which may result in diabetes and ectopic fat deposition in the 
liver. Studies have indicated that let-7 inhibition not only prevents from diabetes 
and fatty liver but also provides a new therapy to reverse and cure them.158 
 
Considering that the alteration of miRNA expression level is closely related to 
the diseases as well as the survival of patients,159 the techniques that are capable 
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of profiling the expressions of miRNAs are important and urgently demanded 
as early diagnosis could help to reduce the mortality rate of patients. Fortunately, 
coupled with their regulatory roles, miRNAs are an extremely stable form of 
nucleic acids which are immune to endogenous RNase degradation.160 Besides, 
they can be easily obtained through body fluids such as blood and the levels of 
miRNAs in blood are stable, reproducible and consistent among individuals of 
the same species,161 hence making miRNAs ideal biomarkers for diagnosis and 
prognosis. However, miRNAs are generally in short length, low cellular 
abundance and there is an extremely high level of homology of down to one 
base difference within a miRNA family. These characteristics of miRNAs make 
their detection challenging as the detection method has to be both highly 
sensitive and selective. Currently, there are already several techniques for 
miRNA detection such as conventional Northern blotting,119, 162 microarray,163 
(RCA),164 and quantitative polymerase chain reaction (qPCR).165 All these 
techniques have made great contributions to miRNA research in the early days 
and some are still popular tools in miRNA research. Nonetheless, each of them 
has its own limitations like tedious procedure, high cost, time consuming, 
inferior selectivity, or poor sensitivity and LOD. For example, Northern blotting, 
whereby the detection of isolated RNAs allows the study of the level of gene 
expression in cells and also size determination, is the most established nucleic 
acid assay and still considered as the “gold standard” of miRNA expression 
analysis. However, its poor sensitivity and LOD in conjunction with its 
inherently tedious procedure and long assay time makes Northern blotting non-




More recently, several homogeneous amplification strategies for miRNAs that 
mainly rely on target recycling amplification to improve the sensitivities and 
obtain lower LODs of miRNA assays have been developed.133, 135, 166-169 Unlike 
heterogeneous assays which intrinsically suffer from poor reproducibility, the 
homogeneous miRNA assays are expected to greatly improve the 
reproducibility and simplify the assay procedure. Among them, the use of a 
duplex-specific nuclease (DSN) to amplify miRNA hybridization events 
appeared very attractive since the amplification process was carried out 
isothermally. As compared to other commonly used enzymatic amplification 
methods such as qPCR and ligase chain reaction (LCR)170 utilizing polymerase 
and ligase respectively, the isothermal miRNA amplification realized by DSN 
completely removes the requirement of a thermal cycler.171 This greatly 
simplifies point-of-care diagnostics. It also implies that the assays are easier to 
use, cost effective and more tolerant to inhibitory components from crude 
samples. Ye’s group133 firstly utilized the DSN signal amplification strategy 
coupled with the Taqman probes to sensitively detect miRNAs. Soon after, this 
DSN amplification strategy has been further developed by other researchers. 
For instance, Lin et al.172 employed backbone-modified molecular beacons for 
miRNA detection with reasonably good sensitivity and satisfactory selectivity. 
Despite achieving an LOD of 0.5 pM within 40 min and the advantages with 
the use of molecular beacons, it also has its limitations such as possible false 
positive signals due to the co-existing of the unhybridized molecular beacons. 
Moreover, the molecular beacons needed to be modified on their backbones, 
making the preparing steps more complex and costly. In another report, Deng 
and co-workers173 proposed a dual-amplification strategy by making use of 
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DNAzyme and achieved excellent sensitivity, LOD and selectivity. 
Unfortunately, dual amplification also means one more catalytic step before 
final detection, making it somehow cumbersome. Degliangeli and his 
colleagues134 recently published a miRNA quantification method by using 
DNA-gold nanoparticle conjugates as detection probes. Nevertheless, the LOD 
of the assay – 5.0 pM after 5 hrs incubation – is not entirely satisfactory as 
compared to other miRNA assays. Meanwhile, a more sensitive miRNA assay 
was reported by Xi et al.174 Through exploiting the differential affinity of WS2 
nanosheets toward short and long oligonucleotides and their efficient 
fluorescence-quenching ability, a miRNA assay was developed. The assay was 
highly sensitive and selective with an LOD of 300 fM. Nonetheless, simple, 
rapid, low cost and ease-to-use miRNA assays with high sensitivity and 
selectivity as well as low LOD suitable for uses at point-of-care are still in great 
demand. To significantly enhance the sensitivity, decrease the LOD and 
simplify the assay procedure, in this report, we proposed a simple, rapid, highly 
sensitive and selective homogeneous miRNA assay that couples magnetic beads 
(MBs) with the DSN for background reduction and signal amplification. By 
conveniently and completely removing unreacted detection probes, minute 
changes in fluorescence intensity of the analyzed solution could be 
unmistakably detected, thereby producing an LOD of 60 fM and a very broad 







3.2 Materials and methods 
3.2.1 Reagents and apparatus 
The DNA detection probes, synthetic miRNAs, and all other oligonucleotides 
were custom-made by Integrated DNA Technologies and their respective 
sequences are listed in Table 3-1.  
Table 3-1. Sequences of synthetic oligonucleotides used in this bioassay 
Name Sequence (5’- 3’) 
Probe 
5’-/5Biosg/T9 AAC TAT ACA ACC TAC TAC CTC 
AT9/36-FAM/-3’ 
Let-7a (miRNA) 
5’-rUrGrA rGrGrU rArGrU rArGrG rUrUrG rUrArU 
rArGrU rU-3’ 
Let-7f (miRNA) 
5’-rUrGrA rGrGrU rArGrU rArGrA rUrUrG rUrArU 
rArGrU rU-3’ 
Let-7d (miRNA) 
5’-rArGrA rGrGrU rArGrU rArGrG rUrUrG rCrArU 
rArGrU rU-3’ 
dT21 5’-TTT TTT TTT TTT TTT TTT TTT-3’ 
 
The DSN was purchased from Evrogen through Genomax (Singapore). 
Dynabeads (M-280 streptavidin-coated), monodispersed with < 5% batch-to-
batch variations, were bought from Life Technologies (Singapore), and their 
TEM images were shown in Figure 3-1.  
 
Ethylenediaminetetraacetic acid (EDTA), disodium salt was obtained from 1st 
Base. The composition of buffer solutions used in this work, including 1 ×, 2 × 
binding and washing (B&W) buffer, and hybridization buffer, was listed in 





Figure 3-1. TEM images of the streptavidin-coated magnetic beads (Dynabeads 
M-280) with diameters of 2.8 µm. 
 
Table 3-2. Composition of all buffers used in this bioassay 
Buffer Composition 
1× Binding and Washing Buffer  
(1× B&W) 
5.0 mM Tris-HCl, 0.5 mM EDTA, 1.0 M NaCl, 
pH 7.5 
2× Binding and Washing Buffer  
(2× B&W) 
10 mM Tris-HCl, 1.0 mM EDTA, 2.0 M NaCl, pH 
7.5 
Hybridization Buffer  
(for Mg2+ Optimization) 
50 mM Tris-HCl, pH 7.54:  
Vary concentration of MgCl2 in buffer from 5.0 to 
40 mM 
Hybridization Buffer  
(for pH Optimization) 
50 mM Tris-HCl, 25 mM MgCl2: 
Vary pH of buffer from 6.5 to 9.0 
Optimized Hybridization 
Buffer 
50 mM Tris-HCl, 25 mM MgCl2, pH 8.0 
 
All solutions were prepared using nuclease-free UP water. The pH values of all 
buffer solutions were adjusted with appropriate amounts of HCl or NaOH. 
Nuclease-free centrifuge tubes (0.65 mL and 2.0 mL) were purchased from 
Scientific Specialties Incorporated (Lodi, CA, USA). Microfuge tubes (0.2 mL) 
were from Thermo Fisher Scientific Incorporated (Waltham, MA, USA) and 
were certified free of DNase, RNase, human and genomic DNA contaminations. 
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Fluorescence measurements were carried out on a Nanodrop 3300 from Thermo 
Fisher Scientific Incorporated. All fluorescence data were collected at 519 nm 
as the fluorescein-capped DNA detection probes have the maximum emission 
wavelength of 519 nm. The excitation wavelength for fluorescein was 495 nm.  
 
3.2.2 Preparation and quantification of DNA detection probe-MB 
conjugates 
The conjugation of the fluorescein-capped DNA detection probes to the 
streptavidin-coated MBs was performed according to the recommended 
procedure. The feeding ratio between the MBs and fluorescein-capped DNA 
detection probes was estimated based on the information provided in the user 
manual of Dynabeads M-280 streptavidin MBs. First, a desired volume of M-
280 streptavidin MBs was placed into a centrifuge tube and the solvent was 
discarded with the help of a permanent magnet. After three careful washings 
with the 1 × B&W buffer, the MBs were dispersed to the 2 × B&W buffer and 
a required amount of dually tagged (biotin at 5’ end and fluorescein at 3’ end) 
DNA detection probes was added. The mixture was gently vortexed for 15 min 
at room temperature to ensure the completion of the interaction between biotin 
and streptavidin. The supernatant was then separated out; its fluorescent 
intensity was determined and was used to estimate the coupling efficiency of 
the DNA detection probes to the MBs. Finally, the DNA detection probe-MB 
conjugates were washed three times with the hybridization buffer, dispersed in 
the hybridization buffer, and stored at 4 ºС for later use. It was estimated that  
4.1 × 105 DNA detection probes were coupled onto each MB, which occupied 
19% of the total capacity of the MBs, leaving enough space for target miRNA 
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hybridization and DSN cleavage. All the fluorescein-related steps were 
conducted in aluminum foil-wrapped centrifuge tubes to prevent from the 
exposure of the content to illumination which may adversely affect the 
fluorescence properties of the fluorescein tags.175 
 
3.2.3 Optimization of experimental conditions and miRNA detection 
All experimental conditions, including the dosage of the DSN, concentration of 
Mg2+, pH of buffer solution, incubation temperature, and incubation time were 
optimized before the detection of the target miRNAs. The concentration of the 
DNA detection probes used in optimization experiments was 100 nM and the 
concentration of the target miRNA was 2.0 nM. For the target miRNA detection, 
30 µL of 100 nM probes were used in the assay with varying concentration of 
the target miRNA. An appropriate amount of the DSN was added to each 
microfuge tube followed by vortexing to thoroughly mix the reaction mixture. 
After incubation, the DSN cleavage process was stopped when the MBs 
together with unreacted DNA detection probes were separated out by the 
permanent magnet. The supernatant then underwent fluorescence measurement. 
The selectivity of the assay was studied by comparing the responses of the target 
miRNA (let-7a) with both one and two-base mismatched miRNA in the let-7 
family, namely let-7f and let-7d, respectively. The concentrations of let-7f, and 










3.2.4 Analysis of miRNA in total RNA extracted from cultured cells  
The celles were cultured under the following culture condition: 5% CO2/95% 
air, 37 ºС. The growth medium for each cell line is as follows. 
HeLa: ATCC-formulated Eagle's Minimum Essential Medium (Catalog No. 30-
2003) + 1% (vol/vol) penicillin-streptomycin + 10% (vol/vol) fetal bovine 
serum (FBS). H1299 (Lung cancer cell): ATCC-formulated RPMI-1640 
Medium (Catalog No. 30-2001) + 1% (vol/vol) penicillin-streptomycin + 10% 
(vol/vol) FBS. MRC-5 (Normal cell): ATCC-formulated Eagle's Minimum 
Essential Medium (Catalog No. 30-2003) + 1% (vol/vol) penicillin-
streptomycin + 10% (vol/vol) FBS. 
 
First, remove and discard the culture medium. Second, rinse the cell with 0.25% 
(w/v) Typsin-0.53mM EDTA solution. Add 3 mL of Trypsin-EDTA solution to 
75 mL flask and observe cells under an inverted microscope until cells are 
dispersed (~ 10 min). Then, add 7 mL of growth medium and aspirate cells by 
gently pipetting. Lastly, transfer aliquots of the cell suspension to new flask and 
incubate at 37 ºС.176-178  
 
Total RNA of cultured cells was extracted using a miRNeasy RNA extraction 
kit (Qiagen V.V., Hilden, Germany) according to the recommended procedure 
and miRNAs in the total RNA were enriched by using a clean-up kit. The yield, 
quality, and concentration of total RNA were routinely examined by UV-Vis 
spectrophotometry. As a model miRNA, let-7a detection in the extracted total 




3.3 Results and discussion 
3.3.1 Assay principle  
DSN is an endonuclease isolated from the hepatiopancreas of Paralithodes 
camtschaticus (the red king crab) Among single-stranded DNAs, DNA 
homoduplexes, single-stranded RNAs, RNA homoduplexes, DNA-RNA 
heteroduplexes, the DSN displays a strong preference for cleaving DNA 
homoduplexes and DNA in DNA-RNA heteroduplexes, i.e. DSN is only active 
towards DNA strands in duplexes particularly. Moreover, the DSN is able to 
discriminate imperfectly matched duplexes from perfectly matched ones.179 
These unique attributes offer new possibilities for the development of 
ultrasensitive nucleic acid assays and are the basis of the proposed miRNA 
assay. As illustrated in Figure 3-2, when the target miRNA strands and the DNA 
detection probes form heteroduplexes, the DSN selectively cleaves the DNA 
detection probes while retains the target miRNA strands intact and release them 
back to solution for next cycle. The cleaved DNA detection probes together with 
their fluorescence tags are dispersed to the solution. A cumulative signal can, 
therefore, be obtained after numerous rounds of the hybridization and DSN 
cleavage cycles after a sufficiently long period of incubation. After the 
incubation, the unreacted DNA detection probes on the MBs are completely 
removed from the reaction mixture by using a permanent magnet. All the 
reaction mixture containing the cleaved DNA detection probes is pipetted out 
while holding the MBs at the bottom of the microfuge tube by the permanent 
magnet, thereby leaving only the cleaved DNA detection probes together with 
their fluorescein tags in the solution for detection. Hence, a negligible 
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background is obtained and the fluorescence intensity of the solution is directly 
associated with the concentration of the target miRNA. 
 
 




3.3.2 Optimization of conditions 
Contrary to the chemical coupling which may suffer from relatively large batch-
to-batch variations in coupling efficiency, the dually tagged DNA detection 
probes offered a simple and highly efficient route to conjugate them onto the 
MBs through strong interaction between the biotin moieties on the DNA 
detection probes and the streptavidin moieties on the surface of the MBs. The 
dissociation constant of biotin-streptavidin conjugates Kd (4 × 10
-14 M) is 
regarded as small enough to warrant robust attachment to the MBs and high 
stability of the attached DNA detection probes on the MB surface.180 Figure 3-
3 indicated that during the first 15 min of incubation, the MBs were already 
completely coated with the DNA detection probes. Before conjugating BF 
oligonucleotides to the MBs, the original BF oligonucleotides solution has quite 
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a high fluorescent intensity as the blue curve indicated; while after conjugation, 
the MBs with the conjugated BF oligonucleotides on their surface were 
separated out by a permanent magnet, and the orange curve indicated the 
fluorescent intensity of the solution containing the excess (free) BF 
oligonucleotides.  
 
Figure 3-3. The fluorescence intensities of the remained BF oligonucleotides 
solution before and after linking BF oligonucleotides to the MBs. 
 
In addition, the utilization of streptavidin molecules as anchoring sites ensures 
appropriate spacing of the DNA detection probes for easy access of the DSN. It 
was estimated that the distance between adjacent DNA probes on MBs is about 
6 nm while the DSN has a size around 4.7 nm calculated from its molecular 
mass of 40 kD.181 In principle, the DSN should be able to freely access to the 




To exploit the DSN cleavage process as a powerful amplification strategy, the 
cleavage of the DNA detection probes from the MBs should be exclusively 
associated with the concentration of the target miRNA or the fluorescence 
intensity must be solely controlled by the hybridization efficiency of the target 
miRNA. Therefore, to have the highest possible sensitivity and lowest LOD as 
well as a straightforward correlation (linear dependence) between the analytical 
signal and the target miRNA concentration, the concentrations of the DSN 
should be kept sufficient in order to capitalize on its amplification power. The 
high concentrations of the DSN imply that the DSN cleavage proceeds much 
more rapidly than the miRNA hybridization process and the DNA detection 
probes are cleaved instantly as soon as they are hybridized with the target 
miRNA strands, thus ensuring that the analytical signal is directly associated 
with the target miRNA concentration and its hybridization time. Insufficient 
amounts of the DSN will likely result in a non-linear behavior between the 
fluorescence intensity and the target miRNA concentration, whereas a high 
amount of the DSN will not only increase the detection cost, but also increase 
the possibility of false positive detection. To maximize the sensitivity and 
minimize the LOD of the assay while keeping its cost low, our attention had to 
be focused on the detection of traces of miRNAs where reasonable amounts of 
the DSN should be sufficient. Indeed, using let-7a as a model target miRNA, 
our experiments showed that the fluorescence intensity increases rapidly with 
the increase in the dosage of the DSN from 0.01 U to 0.30 U and approaches a 
steady-state in the presence of > 0.40 U DSN. It was found that 0.40 U DSN is 
sufficient for the detection of miRNAs down to femtomolar levels. Likewise, 
the concentration of the DNA detection probes should also be kept sufficient to 
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make certain that the cleavage of the DNA detection probes from the MBs is 
solely controlled by the target miRNA hybridization process. Consequently, a 
considerably long period of hybridization, which favors the detection of 
miRNAs at ultralow levels, can be employed. Again, any notable depletion of 
the DNA detection probes will probably result in a non-linear dependence of 
the fluorescence intensity on the target miRNA concentration. Our experiments 
showed that 100 nM of the DNA detection probes is sufficient for the detection 
of target miRNA from femtomolar to nanomolar concentration.  
 
To take full advantage of the DSN cleavage process as a powerful amplification 
strategy for maximizing the assay sensitivity and minimize the LOD, besides 
the dosage of the DSN, all other experimental variables must be optimized. The 
concentration of Mg2+ is crucial to this assay because on one side, a certain 
amount of Mg2+ is necessary to sustain the activity of the DSN as well as the 
efficiency of the miRNA hybridization; while on the other side, the DSN is 
sensitive to the presence of high concentrations of salts. A 10-fold decrease of 
the DSN activity was reported in the presence of 0.20 M NaCl.182 Therefore, an 
appropriate amount of Mg2+ should be present in the solution. From the 
experimental results shown in Figure 3-4, 25 mM of Mg2+ was found to be 
optimal for the assay to maintain efficient miRNA hybridization and maximal 




Figure 3-4. Optimization of the experimental conditions. 2.0 nM target miRNA 
let-7a, 100 nM probes, and 0.4 U DSN. 
 
The pH of the reaction medium is another important variable for the success of 
the assay. It has been observed that the activity of the DSN strongly depends on 
solution pH even though it has a relatively broad pH working range from 3.5 to 
8.5 with the pH optimum at  6.6. Extreme pH values below 3.0 or above 9.0 
will completely inactive the DSN.183 More importantly, the pH value of the 
buffer solution strongly affects the fluorescence of the fluorescein tags. 
Fluorescein is deprotonated in alkaline medium and protonated in acidic 
solution. In either case the conformation of fluorescein molecule is altered and 
subsequently the fluorescent efficiency (quantum yield) of fluorescein is 
significantly diminished. Taking these two aspects into consideration, it was 
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found that pH 8.0 was optimal for the proposed assay, as reflected by the green 
curve in Figure 3-4. 
 
In addition, the incubation temperature is expected to strongly affect both the 
hybridization efficiency and the DSN activity. Generally, the hybridization 
temperature should be 10 to 15 ºС lower than the melting temperature to have 
high hybridization efficiency while maintaining good selectivity. The estimated 
melting temperature of let-7a was  55 ºС under the present experimental 
conditions. In principle, the assay should be performed at temperatures  45 ºС. 
However, the DSN prefers a higher temperature than 45 ºС to attain a better 
activity. The optimal temperature for the DSN to reach its highest activity is 60 
ºС.183 Temperature higher than 60 ºС adversely affects both the activity of the 
DSN and the hybridization efficiency. The blue curve in Figure 3-4 displayed 
the effect of the incubation temperature on the sensitivity and LOD of the assay. 
As seen in Figure 3-4, the lowest LOD was achieved at 40 ºС. 
 
We also investigated the dependence of the fluorescence intensity of the assay 
on the DSN incubation time. As represented in Figure 3-5, the fluorescence 
intensity increased rapidly with the DSN incubation time in the first 60 min and 
then slowly leveled off with prolonged incubation. Our experiments indicated 
that a period of 2 hrs incubation is sufficient although longer incubation time, 
for example 240 min, could further decrease the LOD of assay by  20%. 





Figure 3-5. The dependence of the fluorescence signal on the DSN incubation 
time. 2.0 nM target miRNA let-7a, 100 nM probes, 40 ºС, 0.4 U DSN. 
 
3.3.3 Analytical performance 
Utilizing the optimized experimental conditions, the correlation between the 
fluorescence intensity and the target miRNA concentration was investigated. As 
demonstrated in Figure 3-6, the calibration curve showed a linear dynamic range 
from 100 fM to 2.0 nM with a coefficient of 0.9885. The relative standard 
deviation was less than 10% throughout the linear range from 100 fM to 2.0 nM. 
Figure 3-6b displayed the fluorescence spectra acquired when varied 
concentrations of the target miRNA let-7a used in the study. As can been seen 
from Figure 3-6b, the background signal of the assay, corresponding 0.0 nM of 
the target miRNA, was negligibly small, barely above zero. Obviously, the 
simple magnetic separation of the unreacted DNA detection probes from the 
reaction mixture was very efficient. The engagement of the MBs as the DNA 
detection probe carriers and the two-step procedure – amplification and 
magnetic separation – in this assay had a much lower non-target miRNA-related 
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fluorescent responses simply due to the fact that practically all unreacted 
fluorescence tags are removed before fluorescence measurements, thus 
producing an extremely low background and providing substantial 
improvement in signal/noise ratio. The LOD, estimated as three times of the 
standard deviation of the background, was 60 fM or 1.8 amol. In previous 
reports where the unreacted detection probes co-existed with cleaved ones, 
noticeable fluorescence responses were observed, evidently owing to the 
incomplete quenching the fluorescence tag.133, 134, 174 Therefore, the separation 
of the unreacted DNA detection probes is of paramount importance in 
generating a sensitive fluorescence signal and in significantly reducing 
background fluorescence. The sensitivity and LOD obtained in this assay was 
much better than those of similar assays and comparable to that of qPCR 
miRNA assay. More importantly, the much reduced background fluorescence, 
only 1/10 – 1/100 of those observed in other fluorescence miRNA assays, 
produced an extremely wide linear calibration curve, extending from 100 fM to 
2.0 nM. As comparing to qPCR miRNA assays, through the DSN-mediated 
target cycling, the amplification is accomplished isothermally at 40 ºС, 
suggesting that the proposed assay is easier to implement, more cost effective, 





Figure 3-6. (a) The calibration curve of let-7a (100 nM probes, 0.4 U DSN and 
a period of 2 hrs incubation at 40 ºС) and (b) fluorescence spectra of varied 
concentrations of let-7a.  
 
The selectivity of this assay was investigated through comparing the responses 
of the target miRNA let-7a to the one-base mismatched miRNA let-7f and two-
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base mismatched miRNA let-7d. As shown in Figure 3-7, both one-base 
mismatched let-7f and two-base mismatched let-7d were clearly discriminated 
from let-7a. The signal of the perfectly matched let-7a was 14 times higher than 
that of the one-base mismatched let-7f and 24 times higher than that of the two-
base mismatched let-7d. The excellent selectivity is probably due partly to the 
mismatch discriminability of the DSN and partly to the fact that the DSN 
requires at least 15 perfectly paired bases in the DNA-RNA heteroduplex for 
cleavage. In our assay, the one-base mismatch of let-7f is in the center of the 
total 22 bases. Thus, only 10 or 11 perfectly matched bases are there in the 




Figure 3-7. Responses of the let-7a assay to 2.0 nM of let-7a, let-7f, and let-7d. 
Experimental conditions are as for Figure 3-6. 
 
The proposed bioassay for miRNA here was also compared with its counterparts 
currently exist. As summarized in Table 3-3, compared with the previously 
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published miRNA detection methods, the present work exhibited its superior 
selectivity toward one-base mismatched miRNA family member. Some of the 
works have achieved ultralow LOD down to several attomolar for miRNA 
detection, however, they can not distinguish a specific miRNA among its family 
members with high sequence similarity, which is a significant issue regarding 
to miRNA detection. Meanwhile, the present work is advantageous at the 
simplicity, low cost and repeatability, which are quite attractive for further real 
sample applications.  
 
Table 3-3. Comparison with representative fluorescent detection methods for 
miRNA  


















DSN+Perylene 5 pM 4:1 3.5 hrs + +   + + + + + + +  184 
 







Not realized 30 min + + + + + + + + + + + + + +  133 
 




DSN+AuNP 5 pM Not realized 5 hrs + + + + + + + + + 134 
 






3 aM Not realized > 5 hrs + + + + + + 185 
 








5 fM 11:1 4.5 hrs + + + + + + + + 186 
 








Not realized 1 hr + + + + + + + +  187 
 














3.3.4 Sample analysis 
To evaluate its practicability, the proposed assay was applied to analyze let-7a 
in three total RNA samples extracted from cultured cells. The results were 
summarized in Table 3-4. As seen in Table 3-4, the expression levels of let-7a 
obtained by the proposed assay agreed well with those obtained by qPCR. The 
relative errors associated with the detections were found to be less than 20%. 
As compared to PCR-based assays, the isothermal amplification via the DSN 
facilitated target cycling together with its excellent selectivity is very valuable 
since the freedom from thermal cycling would greatly improve the adaptability 
of the assay for direct miRNA expression profiling with minimal requirement 
of sample preparation. 
 
Table 3-4. Analysis of let-7a in total RNA samples extracted from cultured cells 
 
Lung cancer cells 
(106 copy μg-1) 
HeLa cells 
(106 copy μg-1) 
Normal cells 
(106 copy μg-1) 
This method  1.60.30 3.80.80 5.30.92 




In conclusion, we have developed a simple and highly sensitive assay for 
miRNAs by using MB-carried DNA detection probes coupled with DSN-
facilitated isothermal target cycling amplification. The accumulative nature of 
the target cycling amplification offered a powerful and yet flexible means to 
significantly improve the sensitivity and decrease the LOD of the assay. The 
isothermal amplification strategy greatly improved the suitability in direct 
profiling miRNA expressions with minimal or no sample pretreatments. The 
MBs ensured a complete removal of possible interference from unreacted DNA 
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detection probes before fluorescence measurements, thus producing an ultralow 
fluorescence background and an extended dynamic range. The simplicity, high 
sensitivity, low LOD and the freedom from thermal amplification and miRNA 
tagging are some of the interesting features for the development of a simple, 




Chapter 4. Application of Catalytic Nucleic Acids in Bioassay for 
MicroRNA Part I: Synthesis of Polyaniline via DNAzyme-Catalyzed 





4.1 Introduction  
As one of the important classes of conducting polymers, polyaniline (PANI) has 
been extensively studied due to its high conductivity in its doped (oxidized) 
state189 and its intriguing electrochemical, electronic, optical, and electro-
optical properties.190 The conjugation mechanism of PANI is unique among the 
conducting polymers owing to a combination of benzenoid and quinoid rings 
leading to three different oxidation states, namely leucoemeraldine, emeraldine, 
and pernigraniline.191 It has been found that PANI exhibits insulator-to-
conductor transitions and multiple color changes depending on its oxidation 
states and solution pH. PANI can be doped either by protonation with a protonic 
acid or by charge-transfer with an oxidation agent and its electronic and optical 
properties may be controlled reversibly by varying the doping level. Technical 
applications of PANI include biosensors,192-194 corrosion protection,195 energy-
storage devices,196 and antistatic coating.197 PANI has also been commonly 
utilized to fabricate nanoelectronics including printed circuit boards (PCB),198 
organic light emitting diodes (LEDs)199 and organic lightweight batteries.200  
 
PANI is commonly synthesized by oxidative polymerization of aniline in 
strongly acidic media either chemically201-205 or electrochemically.206-208 
Chemical polymerization of aniline is performed using strong oxidants such as 
ferric salts,202 bichromate,203 permanganate,204 or peroxydisulfate.205 These 
oxidants are able to oxidize aniline under highly acidic conditions, thus leading 
to the formation of chemically active cation radicals of aniline. The cation 
radicals subsequently react with aniline molecules, yielding oligomers and 
finally PANI. The reaction is far from being environmentally friendly because 
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of high acid and oxidant concentrations, and the use of these oxidants also 
generates significant amounts of by-products which require further steps of final 
product purification. Moreover, the reaction of chemical polymerization of 
aniline is not kinetically controllable. On the other hand, electrochemical 
polymerization of aniline and its derivatives is typically carried out in highly 
acidic aqueous solutions by the application of a constant voltage/current or by 
potential ramping.207 In comparison, electrochemical polymerization of aniline 
has several advantages over chemical polymerization since the process is clean 
and no toxic oxidants involved, and the synthesized PANI possesses flexible 
electrical properties.208 Electrochemical polymerization can also be used to coat 
electrodes because electrochemical polymerization/deposition enables coating 
of PANI on rather complex geometries. However, the electrochemical methods 
have some limitations. For instance, it is difficult to prepare a large amount of 
PANI in a short period of time because the polymerization is carried out only 
on the surface of the electrode. In addition, PANI synthesized by both chemical 
and electrochemical approaches is often confronted with over-oxidation state 
that may result in the degradation of PANI.209  
 
In recent years, PANI synthesis via biocatalytic approaches using enzymes has 
become more and more attractive as an alternative synthetic route.210 Unlike the 
chemical approaches where a large amount of toxic materials are released as by-
products, biocatalytic polymerization of aniline using enzymes is advantageous 
since it is a very simple one-step process carried under mild conditions211 and 
does not require strong acidic media and highly toxic oxidizing reagents or 
additional purification steps. It is therefore an environmentally friendly 
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approach with high potential for industrial scale production in high yield 
without contaminant by-products of oxidant degradation due to the efficiency 
of the biocatalyst.212, 213 Moreover, the structure and solubility of PANI can be 
greatly improved by optimizing the reaction conditions, which is beneficial for 
further processing. Horseradish peroxidase (HRP) was first used for the 
synthesis of PANI.210, 214 HRP is an oxidoreductase which catalyzes the radical 
polymerization of aniline in the presence of a mild oxidizing agent such as 
hydrogen peroxide. In the presence of hydrogen peroxide, HRP catalyzes the 
oxidation of aromatic amines and phenols to generate free radicals. In the case 
of aniline, the aniline free radicals coupling to produce dimers and further 
oxidation and coupling reactions result in the formation of PANI. Other 
enzymes such as laccase,215 palm tree peroxidase,216 bilirubin oxidase,217 
soybean peroxidase,218 and glucose oxidase219 were also used as catalysts for 
aniline polymerization under mild conditions in aqueous media. It should be 
noted that enzymes are very sensitive to hydrogen peroxide concentration which 
usually requires stepwise addition of diluted hydrogen peroxide to the reaction 
medium. Also, enzymes can be easily denatured by environmental changes 
because a minor alteration of their native protein conformation could result in 
complete loss of their catalytic activity.  
 
More recently, it has been observed that single-stranded nucleic acids with 
specific sequences coupled with cofactors are catalytic through forming higher 
order structures – the so called G-quadruplexes ‒ DNAzymes. DNAzymes are 
DNA molecules that have the ability to perform chemical reactions, such as 
catalytic action. One interesting example of DNAzymes that reveals peroxidase-
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like activity is a supramolecular complex between hemin and a single-stranded 
guanine-rich nucleic acid.51 It was suggested that the intercalation of hemin into 
the guanine quadruplex docked layers of the nucleic acid leads to the 
biocatalytic functionality.50 It has also been observed that this G-quadruplex 
DNAzyme can catalyze the polymerization of several aromatic compounds and 
produce according polymers.220, 221 In the present work, a novel approach for 
the synthesis of PANI based on the G-quadruplex DNAzyme was developed. 
The proposed approach addresses the limitations of both enzymatic and 
chemical polymerization of aniline. Comparing to natural peroxidases, the 
DNAzyme is much more stable and less expensive to produce by DNA 
synthesis. More importantly, unlike enzymes, the DNAzyme remains active in 
a wide range of hydrogen peroxide concentration and can be reversibly 
denatured and renatured many times without losing its activity. Therefore, the 
use of the DNAzyme as catalyst for aniline polymerization represents a viable 
alternative route in comparison with peroxidase-based synthesis. It is 
environmentally friendly and does not require a stepwise addition of diluted 
hydrogen peroxide to a reaction medium in contrast to the peroxidase-based 
approaches. The application of this synthesis in bioassay will be demonstrated 
in Chapter 5.  
 
4.2 Experimental section  
4.2.1 Reagents and apparatus 
Aniline (> 99.5%), Polyacrylic acid (2100 sodium salt) (PAA), and hemin (> 
98%, HPLC) were purchased from Sigma-Aldrich. Oligonucleotide (5’-GGT 
GGT GGT GGT TGT GGT GGT GGT GG-3’) for construction of DNAzyme 
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was custom made by Integrated DNA Technologies Incorporated. All the 
reagents were from Sigma-Aldrich and used without further purification unless 
specified. A 0.10 M phosphate buffer (PB) containing 0.10 M potassium 
chloride (KCl) was used in the aniline polymerization study and its pH was 
adjusted by adding an appropriate amount of sodium hydroxide (NaOH) or 
phosphoric acid (H3PO4) solution. All aqueous solutions were freshly prepared 
with UP water.  
 
FT-IR spectroscopic experiments were performed with a Bio-Rad Excalibur 
Series FTS 3000 spectrometer and the spectra were collected after 20 scans 
between 4000‒400 cm-1 at a resolution of 4 cm-1. Cyclic voltammetric tests were 
conducted with a CHI 660D electrochemical analyzer (CH Instrument, Austin, 
TX, USA). A three-electrode system was used with a glassy carbon electrode 
(GCE) as the working electrode, saturated calomel electrode (SCE) as the 
reference electrode, and platinum wire as the auxiliary electrode, respectively. 
All potentials reported in this work were referred to the SCE. The standard four-
probe technique using an Agilent 4157 parameter analyzer from Agilent 
Technologies (Santa Clara, CA, USA) in conjunction with a probe station was 
employed to measure the electrical conductivity of compressed pellets of 
polyaniline samples. A gel permeation chromatograph (GPC) comprising 
Waters Model 515 HPLC pumps and a Waters Model 2414 refractive index 
detector (Milford, MA, USA) was used to determine the molecular weight of 
the PANI.  Scanning electron microscopic (SEM) image was collected on a 
JEOL JSM-6701F Field Emission Scanning Electron Microscope (FESEM) 
provided by JEOL USA Incorporated (Peabody, MA, USA). 
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4.2.2 Preparation of the G-quadruplex DNAzyme 
5.0 mM stock solution of hemin was prepared by dissolving 50 µmol of hemin 
in 10 mL DMSO and stored at -20 ºС in dark. The working solution of hemin 
(100 μM) was prepared by diluting the stock solution with UP water. 100 µM 
the oligonucleotide solution was prepared by dissolving an appropriate amount 
of the oligonucleotide in 0.10 M KCl and then heated to 88 ºС for 10 min; after 
which the solution was gradually cooled down to room temperature in 20 min.222 
The DNAzyme solution (50 µM) was prepared by adding dropwise 1.0 mL of 
the 100 μM hemin solution to 1.0 mL of the oligonucleotide solution. The 
mixture was incubated for 40 min at room temperature to fold the G-quadruplex 
and form the DNAzyme (G-quadruplex hemin complex). 
 
4.2.3 DNAzyme-catalyzed polymerization of aniline 
50 mM aniline/PAA (1:1) solutions with different pH values ranging from 2.0 
to 5.0 were prepared in 0.10 M PB buffer. 2.0 μM the DNAzyme and 50 mM 
hydrogen peroxide (final concentration) were then added to the aniline/PAA 
solutions to initiate aniline polymerization. PAA in the solutions was used as a 
polyelectrolyte to procure a more ordered para-linked PANI with fewer 
branches and increase the solubility of the synthesized PANI in aqueous 
solution.223 UV-Vis spectra of the reaction mixture at 750 nm were recorded 
with the proceeding of the polymerization. The same mixture without the 
DNAzyme was used as control and its UV-Vis spectra were also recorded. In 
the mechanistic study of the polymerization reaction, the concentration of one 
substrate was fixed and that of the second substrate was varied. UV-Vis spectra 
were collected immediately with a 15-s interval. The reciprocal of the initial 
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reaction rate versus the reciprocal of substrate concentration was plotted. Each 
point was repeated for three times. 
 
4.3 Results and discussion 
4.3.1 DNAzyme-catalyzed polymerization of aniline 
It was reported that certain DNAzymes, such as the G-quadruplex-hemin 
DNAzyme, exhibit peroxidase-like activities in the presence of peroxidase 
substrates and hydrogen peroxide, thus offering new possibilities to engage 
DNAzymes in biocatalytic applications.51, 52, 224 Compared to the bulky and 
fragile peroxidases, their small size and high chemical stability make them 
attractive candidates to be used as efficient catalysts in organic synthesis and 
polymer synthesis. In addition, it is critical that the polymerization of aniline 
should be carried out in an acidic medium with a pH value below the pKa value 
of aniline (pKa  4.63), to effectively utilize the polyanionic template by 
forming electrostatic adducts along PAA between cationic aniline molecules 
and anionic acrylic acid moieties and to minimize the parasitic branching of 
PANI.225 Unfortunately, most natural enzymes are active and stable only around 
neutral pH values. In contrast, the chemical nature of the DNAzyme may be 





Figure 4-1. (A) Photographs of the reaction mixtures (50 mM aniline/PAA + 
50 mM hydrogen peroxide + 2.0 μM the DNAzyme) at different pH values and 
(B) Different structures of PANI: (a) Leucoemeraldine, (b) Emeraldine base 
(EB), (c) Emeraldine salt (ES), (d) Pernigraniline, (e) Ortho- and para-
substituted carbon-carbon, carbon-nitrogen bond structure. (C) DNAzyme-
catalyzed polymerization of aniline in the presence of hydrogen peroxide.   
 
To demonstrate this concept, we first evaluated the catalytic activity of the 
DNAzyme in the oxidation and polymerization of aniline. It was observed that 
in accordance with the HRP-catalyzed polymerization of aniline, the reaction 
between aniline and hydrogen peroxide in the presence of the DNAzyme 
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produced exactly the same colored products (Figure 4-1). As seen in Figure 4-
1A, similar to the HRP-catalyzed oxidation and polymerization of aniline,226 a 
blue-green color developed immediately after spiking a tiny amount of the 
DNAzyme ( 2.0 M) into a mixture of 50 mM aniline/PAA and 50 mM 
hydrogen peroxide at pH < 4.0; while the color of the reaction mixture at pH > 
4.0 was yellow. The blue-green product is believed to be emeraldine base, which 
is half-oxidized state of PANI (Figure 4-1B (b)). This emeraldine base can be 
easily doped by proton and consequently transformed to the emeraldine salt 
(Figure 4-1B (c)), which is the most popular state of PANI since it has an 
excellent electrical conductivity. The emeraldine base can also be further 
oxidized to the fully-oxidized pernigraniline (Figure 4-1B (d)) after a prolonged 
period of polymerization. In addition, before forming emeraldine base, there is 
a state of PANI that cannot be recognized by naked eye ‒ leucoemeraldine 
(Figure 4-1B (a)). It is the fully-reduced state of PANI with white or clear in 
color. As to the yellow product, it is likely the mixture of ortho- and para-
substituted carbon-carbon, carbon-nitrogen bond structure23 and aniline 
oligomers227 (Figure 4-1B (e)).  
 
As shown in Figure 4-2, the catalytic polymerization of aniline in the presence 
of the DNAzyme has two UV-Vis absorption peaks, one sharp peak at  410 
nm and another broad peak at  750 nm. As the polymerization proceeded, the 
absorbances for both peaks intensified. The UV-Vis spectra are in good 
agreement with those found in literature.226 Unfortunately, the DNAzyme used 
in this polymerization system has a sharp UV-Vis adsorption peak at  410 nm 
due to the chromogenic hemin, which may interfere with the analysis of the 
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polymerization process. This interference was circumvented by using the 
absorbance data at 750 nm. Nonetheless, all the data induced from the 
absorbance at 750 nm were generally consistent with those obtained at 410 nm. 
The absorbance at 750 nm was therefore utilized to investigate the kinetics of 
the polymerization of aniline in the following sections. 
 
Figure 4-2. UV-Vis spectra of the polymerization of aniline oxidized by 
hydrogen peroxide in the presence of the DNAzyme. The working solution 
contained 50 mM aniline/PAA (1:1), 2.0 μM the DNAzyme and 50 mM 
hydrogen peroxide in pH 3.0 0.10 M PB buffer. From bottom to top: 0, 15, 30, 





















Figure 4-3. (A) pH optimization of aniline polymerization. Working solution: 
50 mM aniline/PAA, with (■) and without (▲) 2.0 μM the DNAzyme, and 50 
mM hydrogen peroxide in phosphate buffer with different pH values ranging 
from 2.0 to 5.0. UV-Vis measurements were carried out 6 min later after starting 
the polymerization. (B) The effect of pH on the extinction coefficient of the 
synthesized PANI.  
 
From the pH optimization experiments depicted in Figure 4-3A, pH 3.0 was 
found to be optimal for the DNAzyme-catalyzed polymerization of aniline. 
When the solution pH was higher than 4.0, the polymerization rate was 
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substantially suppressed, judging by the much slower change in the absorbance 
at 750 nm. Meanwhile, to rule out the possibility of the effect of pH on the 
extinction coefficient of PANI, the optical properties of the synthesized PANI 
was thoroughly investigated. PANI synthesized at pH 3.5 was separated by 
centrifugation at 15000 rpm. Then it was dispersed to 0.10 M PB buffers with 
different pH values. As can be seen in Figure 4-3B, the influence of pH on the 
extinction coefficient of PANI was negligible comparing to the drastic changes 
in the polymerization of aniline under different pH values. The average 
molecular weight of the synthesized PANI under the optimal conditions was 
found to be 51300.  
 
As shown in Figure 4-4, the reaction rate increased with the increase of the 
concentration of the oxidizing agent hydrogen peroxide. It was shown that the 
reaction rate approached to its maximum in the presence of  50 mM of 
hydrogen peroxide. Also, it was shown that the reaction rate can be conveniently 
controlled at desired levels just by simply adjusting the concentration of 
hydrogen peroxide. However, further increasing in hydrogen peroxide 
concentration was little beneficial to the polymerization of aniline. On the 
contrary, high concentrations of hydrogen peroxide may be detrimental since a 
considerable amount of the PANI may be over-oxidized or undergo the 
undesired ortho-branching which will have a negative impact on the 
conductivity of the aniline. On the other hand, in the commonly used HRP-
catalyzed polymerization of PANI, the concentration of hydrogen peroxide can 
never reach such a high level as HRP will be quickly deactivated in the presence 





Figure 4-4. Effect of the amount of hydrogen peroxide on the reaction rate of 
aniline polymerization. Working solution: 50 mM aniline/PAA, 2.0 μM 
DNAzyme and different concentrations of hydrogen peroxide in the phosphate 
buffer (pH 3.0).  
 
4.3.3 Kinetics of the DNAzyme-catalyzed polymerization of aniline 
It was found that the initial rate of polymerization varied linearly with the 
concentration of the DNAzyme, suggesting that the polymerization of aniline is 
first-order with respect to the DNAzyme. This is a good indication that the 
catalytic process may obey the Michaelis-Menten kinetics.228 And more 
importantly, the linear dependence on the DNAzyme concentration strongly 
suggests that the DNAzyme is stable in the reaction medium. To gain insight in 
the mechanism of the catalytic polymerization of aniline in the presence of the 
DNAzyme, further investigations were conducted over wide ranges of aniline 
and hydrogen peroxide concentrations. Varying the concentrations of aniline 
and hydrogen peroxide, a series of experiments were carried out to explore the 






Figure 4-5. Double-reciprocal plots of the catalytic activity of 2.0 μM 
DNAzyme at a fixed concentration of one substrate and varying concentration 
of the second substrate. 
 
Figure 4-5 shows double reciprocal plots of initial polymerization rate versus 
one substrate concentration, obtained at predetermined concentrations of the 
second substrate. Good linearity (R2 > 0.99) was obtained throughout the 
experiments. These linear plots strongly suggest that the polymerization process 
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obeys the Michaelis-Menten kinetic mechanism as it accords with the classical 









     (Eq. 1) 
The linear correlation between the initial polymerization rate and the 
concentration of substrate will bring great benefit for its future applications in 
chemical sensors and biosensors. That is because such a feature will simplify 
the relationship between the analytical signal and the analyte concentration, 
making the data processing concise and easily understood. 
 
In addition, when the concentration of one substrate was preset and the 
concentration of the other substrate was varied, it was found that these linear 
double-reciprocal plots are parallel to each other, i.e. the slopes of these plots 
are the same. This is the typical characteristic of the ping-pong mechanism,229 
demonstrating that the DNAzyme will bind and react with the first substrate and 
release the first product before binding and reacting with the second substrate. 
 
4.3.4 Characterization of the polymerization product 
FT-IR spectroscopy was utilized to characterize the synthesized PANI. Figure 
4-6 depicts the FT-IR spectrum of the proton doped half-oxidized PANI, which 
was green in color. Proton doping was accomplished by treating the as-
synthesized PANI in 2.0 M HCl. As seen in the spectrum, the adsorption peaks 
at 3450 and 3235 cm-1 can be assigned to the asymmetric and anti-symmetric –
NH+– stretching of PANI.230 The absorption band at 2920 cm-1 belongs to C–H 
vibration.231 The two very sharp bands at 1572 and 1500 cm-1 are due to quinone 
and benzene ring deformation.232 The C–N stretching of the secondary aromatic 
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amine is located at 1300 cm-1. The band at 1133 cm-1 is originated from 
Q=NH+–B or B–NH+–B after doping (Q = quinoid unit, B = benzoid unit) and 
the band at 820 cm-1 is assigned to C–H out of plane bending of para-
substitution pattern, indicating a head-to-tail coupling of aniline.233 The FT-IR 
spectrum confirms that the reaction product between aniline and hydrogen 
peroxide catalyzed by the DNAzyme is PANI in its emeraldine salt form.  
 
Figure 4-6. FT-IR spectrum of the proton doped half-oxidized PANI 
(emeraldine salt). 
 
Supportive evidence of the formation of PANI can be found in cyclic 
voltammogram of the reaction product coated electrode. As mentioned early, 
PANI exists in three different oxidation states which can be conveniently 
interconverted by electrochemical means and cyclic voltammetry in 
particular.234 Moreover, an understanding of inter-conversion of various 
oxidation states of PANI produced can also be conveniently studied by cyclic 
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voltammetry. A cyclic voltammogram of the synthesized PANI is shown in 
Figure 4-7.  Similar to PANI prepared by conventional methods,235, 236 two pairs 
of current peaks centered at 0.20 and 0.49 V were observed. These peaks can be 
assigned to the oxidation of PANI from leucoemeraldine to emeraldine and to 
further oxidation from emeraldine to pernigraniline.234-236 At potentials more 
cathodic that the first oxidation peak of 0.26 V, PANI is in its non-conducting 
leucoemeraldine state. As the potential is swept more anodically, the current 
rises sharply and peaks at 0.26 V due to the partial oxidation of PANI to yield 
the emeraldine salt form. The complete oxidation peak of the polymer is then 
obtained at 0.51 V at which point the emeraldine salt is converted to the non-
conducting pernigraniline salt. Upon potential reversal, two reduction peaks 
appeared at 0.47 and 0.15 V, corresponding to the reduction of pernigraniline to 
emeraldine and emeraldine to leucoemeraldine, respectively. The inter-
conversion of different structural forms could be done repetitively without any 
shifts in peaks or changes in the repetitive cyclic voltammetric scans. It is the 
partially oxidized, protonated form of PANI, known as the emeraldine salt that 
is of particularly interest as it is responsible for PANI’s electron conductivity. 
 
Furthermore, SEM images of the PANI were collected in order to characterize 
the morphology of the synthesized PANI. As seen in Figure 4-8, the 
morphological characteristic of the synthesized PANI is quite similar to those 
obtained in a in previous study.237 The linear structure with an average diameter 
at around 90 nm can be clearly identified, thus validating that linear PANI 






Figure 4-7. A cyclic voltammogram of PANI on GCE in 2.0 M HCl aqueous 










4.3.5 Proton doping 
According to previous studies, the PANI synthesized at pH 3.0 was estimated 
to have an electrical conductivity around 10-6 S/cm,238 which was in the 
semiconductor regime; while after doping, the electrical conductivity can be 
increased to as high as 10‒103 S/cm,237 closing to that of conducting materials. 
Indeed, the conductivity of the as-synthesized PANI in the pH 3.0 PB buffer 
was found to be  3.8 × 10-6 S/cm, whereas the conductivity of the PANI after 
doping in 2.0 M HCl was significantly enhanced to 180 S/cm approaching that 
of metal conductors. Such a characteristic of the adjustable electrical 
conductivity offers ample opportunities to construct electrical/electrochemical 
bioassays considering that materials with designated electrical conductivities 
can now be fabricated instead of finding various materials to fit in different 
devices. Furthermore, since H+ doping is reversible,239 PANI may also act as an 
“on-off” switch, i.e. when PANI is doped, it is conductive and thus turns on the 
switch that allows electric current to flow through; while after dedoping, it is 
insulating and turns off the switch that would block the current at that point.194 
Based on such a simple mechanism, interesting technical applications such as 
environmental monitoring or biosensing are expected. 
 
4.4 Conclusion 
In summary, it was demonstrated for the first time that the G-quadruplex-hemin 
DNAzyme effectively catalyzes the polymerization of aniline under acidic 
conditions. The DNAzyme in this study consists of single-stranded DNA and 
hemin mimicking that of peroxidase. Such a peroxidase-mimicking catalyst is 
more tolerant to the environmental conditions than its natural peroxidase 
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counterparts. For example, HRP will lose its activity once the concentration of 
hydrogen peroxide in working solution is ≥ 10 mM or the pH is ≤ 4.5. In contrast, 
the DNAzyme can still maintain a good activity under acidic conditions (e.g. 
pH 2.5) or a much higher hydrogen peroxide concentration up to several 
hundred millimolars. Due to its robustness, the DNAzyme can be employed as 
an attractive alternative to peroxidases under extreme conditions. 
Predominantly para-coupled PANI with minimal branching can be conveniently 
synthesized in pH 2.5‒3.0 phosphate buffer in the presence of a stoichiometric 
amount of hydrogen peroxide. Since the reaction conditions are mild and no 
toxic by-products are released during the oxidative polymerization of aniline, 
the proposed DNAzyme-catalyzed approach is environmentally friendlier than 
the conventional chemical routes. The much higher concentration of hydrogen 
peroxide allowed in the system implies a simpler and more efficient PANI 
synthesis route. In principle, this approach may be extended to the synthesis of 






Chapter 5. Application of Catalytic Nucleic Acids in Bioassay for 
MicroRNA Part II: A Highly Sensitive MicroRNA Biosensor Based on 








Because of the emerging diagnostic and prognostic values of miRNAs, 
intensive research efforts have been devoted to the development of miRNA 
assays for uses at point-of-care. It is of paramount importance that the method 
for miRNA expression profiling should be highly sensitive, selective, and only 
analyze mature miRNAs as they are the active form of miRNAs. Toward this 
goal, label-free miRNA assays represent a group of attractive candidates for 
miRNAs expression analysis, enabling multiplexed miRNA expression 
profiling with much simplified protocols and with minimal sample preparation. 
So far, several label-free approaches, such as Taqman probe-based 
fluorometry,133 silver nanorod-based SERS,240 nanomechanic atomic force 
microscopy,241 dynamic piezoelectric cantilever,242 stacking-hybridized 
universal tag,243, 244 single-stranded DNA binding protein-assisted capillary-
electrophoresis168, 245, nanoparticle-based colorimetry,135, 246 and 
electrochemical biosensors220, 247 have been reported. Among them, the 
development of label-free electrochemical biosensors appears especially 
appealing, particularly electrochemical impedance spectroscopy (EIS)-based 
label-free biosensors. The inherent miniaturization of electrochemical 
biosensors and their compatibility with standard microfabrication and 
semiconductor technologies, coupled with high sensitivity and low LOD 
assured by chemical/electrochemical amplification strategies, provide 
tremendous opportunities for the electrochemical biosensors to play a 
significant role in future miRNA expression analysis. Their high portability and 
affordability could allow miRNAs expression to be profiled in a decentralized 




To date, several EIS approaches have been attempted in the development of 
miRNA biosensors. For example, based on ruthenium oxide (RuO2) 
nanoparticle-initiated deposition of an insulating film, EIS detection of miRNAs 
can be conveniently performed after the miRNAs are tagged with 
RuO2 nanoparticles.
41 However, RuO2-tagging procedure is a major drawback. 
More recently, on the basis of catalyzed deposition of poly(3,3-
dimethoxybenzidine) by horse reddish peroxidase,247 label-free EIS biosensors 
for miRNAs were reported. Thereafter, LODs down to 2.0 fM were observed. 
The multistep procedure in the preparation of biosensors or in the detection of 
miRNAs may hinder its further development. 
 
To further enhance the sensitivity, decrease the LOD and simplify the detection 
protocol, a simple and yet highly sensitive biosensor for label-free detection of 
miRNAs was described in this report. Through incorporating a cumulative 
signal amplification mechanism – the hybridized target miRNA-guided 
deposition of polyaniline (PANI), label-free detection of miRNAs was realized 
by measuring the charge transfer resistance (Rct) in EIS. As compared to 
previous reports, the procedure was simplified and the much higher efficiency 
in the polymerization of aniline and the subsequent deposition of PANI resulted 
in a sub-femtomolar LOD. 
 
5.2 Experimental section 
5.2.1 Materials and reagents 
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Cysteine-terminated PNA CPs were custom-made by Biosynthesis Incorporated. 
(Lewisville, TX, USA) and used as received for the construction of the 
respective miRNA biosensors. Synthetic let-7 miRNAs (see in Table 5-1) and 
oligonucleotides for construction of the DNAzyme were from Integrated DNA 
Technologies. Freshly-distilled aniline was used in the deposition of PANI. All 
other chemicals of certified analytical grade were obtained from Sigma-Aldrich 
and used without further purification. All aqueous solutions were freshly 
prepared with UP water. A pH 8.0 of 0.10 M phosphate buffer was used as the 
hybridization and washing buffer. A pH 3.0 of 0.10 M potassium phosphate 
buffer containing 50 mM aniline, 400 mM hydrogen peroxide, and 10 µM 
DNAzyme was used as the PANI deposition cocktail. The PNA CP solution 
used for the preparation of the biosensor was typically 2.0 μM.248 
 
Table 5-1. MicroRNA sequences of let-7 family 
Name Sequence (5’- 3’) 
Let-7a (miRNA) 
5’-rUrGrA rGrGrU rArGrU rArGrG rUrUrG 
rUrArU rArGrU rU-3’ 
Let-7b (miRNA) 
5’-rUrGrA rGrGrU rArGrU rArGrG rUrUrG 
rUrGrU rGrGrU rU-3’ 
Let-7c (miRNA) 
5’-rUrGrA rGrGrU rArGrU rArGrG rUrUrG 
rUrArU rGrGrU rU-3’ 
 
UV−Vis experiments for the quantification of RNA samples were conducted on 
a NanoDrop 1000 spectrophotometer provided by Thermo Scientific 
Incorporated. All electrochemical experiments were performed with a Zennium 
electrochemical workstation supplied by Zahner Elektrik (Kronach, Bavaria, 
Germany) using a conventional three-electrode system consisting of the 
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biosensor, a nonleak Ag/AgCl (3.0 M NaCl) reference electrode from Cypress 
Systems (Lawrence, KS, USA), and a coiled platinum wire counter electrode. 
All electrochemical experiments were carried out at room temperature. All 
potentials reported in this work were referred to the Ag/AgCl reference 
electrode.  
 
EIS experiments were carried out at conducted at E0’ of Ru(NH3)6
3+/2+ (-0.11 V) 
over a frequency range from 10 mHz to 1.0 MHz with a 5-mV sinusoidal voltage 
perturbation. The EIS testing solution was made of pH 12.0 0.20 M phosphate 
buffer containing 2.5 mM of Ru(NH3)6Cl3/2.5 mM Ru(NH3)6Cl2. Ru(NH3)6Cl3/ 
Ru(NH3)6Cl2 in the phosphate buffer served as redox probes so as to perform 
EIS. 
 
5.2.2 Biosensor fabrication 
A cleaned gold bead electrode with a predominant (111) faceting of the surface 
(Figure 5-1 insert) was incubated in 100 µL of 2.0 μM PNA solution in a sealed 
centrifuge tube for 4 hrs at room temperature. After the incubation, the electrode 
was washed with 1:1 (v/v) mixture of water and acetonitrile, water, respectively, 
and dried in a stream of Ar. The PNA CP coated electrode was further incubated 
in 1.0 mg/mL cysteine for 2 hrs during which PNA molecules realign their 
molecular axes with the normal surface. The surface coverage of the PNA CP 
monolayer, estimated electrochemically using a published procedure,249 was 
found to be in the range of 11.8–13.5 pmol/cm2. The biosensor was stable for at 
least two months when stored in a clean environment. 
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Figure 5-1. EIS spectra of (1) the control and (2) the miRNA hybridized 
biosensor before PANI deposition. 100 fM let-7b and 60 min hybridization at 
50 ºС. Inset: Scanning tunneling microscopic image of the gold bead electrode. 
 
5.2.3 MicroRNA hybridization and EIS detection  
MicroRNA hybridization, DNAzyme-catalyzed polymerization of aniline, and 
the hybridized miRNA-guided deposition of PANI were performed as follows: 
The PNA CP coated gold bead electrode (biosensor) was immersed in 100 μL 
of the hybridization buffer containing a target miRNA and incubated in a 
controlled environment at 50 ºС for 60 min. After a stringent wash at 60 ºС with 
the hybridization buffer, the hybridized biosensor was then incubated in 100 μL 
of the PANI deposition cocktail for 30 min at room temperature. The biosensor 
was thoroughly rinsed with the pH 3.0 0.10 M potassium phosphate buffer and 
water to remove any residual DNAzyme and aniline monomer. Finally, EIS 
measurements were performed in the pH 12 0.20 M phosphate buffer containing 
2.5 mM Ru(NH3)6Cl3/2.5 mM Ru(NH3)6Cl2. Data were reported as an average 




5.3 Results and discussion 
5.3.1 Detection scheme 
The principal steps in the operation of the biosensor are schematically shown 
in Figure 5-2. A monolayer of charge neutral PNA CPs, acting as a bioaffinitive 
interface, is self-assembled on the surface of the gold bead electrode. To 
improve the quality and stability of the PNA CP monolayer and to minimize 
non-specific deposition of PANI, cysteine is used to fill in the defects of the 
PNA monolayer, forming a mixed monolayer. Incubation of the biosensor in 
the hybridization buffer containing the target miRNA brings the target miRNA 
strands together with a high density of negative charges onto the biosensor (step 
A). A subsequent incubation of the hybridized biosensor in a cocktail consisting 
of the DNAzyme, aniline, and hydrogen peroxide results in the oxidative 
polymerization of aniline catalyzed by the DNAzyme and the deposition of 
PANI guided by the anionic target miRNA strands hybridized to the PNA CPs. 
Strong electrostatic attraction between anionic miRNA strands and protonated 
aniline molecules produces a high concentration of protonated aniline and 
creates a high concentration of protons (acidity) at the biosensor surface. The 
high concentration of aniline and high acidity greatly facilitate the 
polymerization aniline and the deposition of PANI in the presence of a catalyst 
(the DNAzyme) and an oxidant (hydrogen peroxide). Oxidative polymerization 
of aniline is catalytically initiated by the DNAzyme and the deposition of PANI 
is guided by the hybridized target miRNA strands at the biosensor surface (step 
B). The excellent electron-transfer impeding power (insulating power) of the 
deposited PANI in alkaline medium allows EIS detection of the target miRNA 
(step C). High sensitivity and low LOD can be conveniently realized after a 
109 
 
sufficiently long period of incubation in the PANI deposition cocktail. The 
utilization of neutral PNA instead of anionic DNA in the biosensor effectively 
alleviates the undesired (unrelated to miRNA hybridization) adsorption of 
aniline molecules and their subsequent polymerization and deposition, thus 
producing a minimal background and facilitating the detection of miRNA at 
ultralow levels.  
 
 
Figure 5-2. Schematic of the working principle of the label-free miRNA 
biosensor. (A) miRNA hybridization, (B) hybridized miRNA-guided PANI 
deposition, and (C) EIS measurement. 
 
 
5.3.2 Feasibility study 
It was reported that in the presence of polyanionic templates such as nucleic 
acid molecules, the formation of PANI occurs exclusively along the polyanionic 
molecules.250 It was also reported that many G-rich DNA sequences are able to 
form G-quadruplexes and display peroxidase-like activities after complexing 
with hemin, known as DNAzyme.50 Similar to HRP, DNAzyme is capable of 
initiating the polymerization and subsequent deposition of PANI guided by 
prefabricated DNA nanostructures.251 The time-dependent study of the 
deposition of PANI indicated that the growth of PANI occurs exclusively along 
the DNA templates.251 On the other hand, it sounds a bit peculiar that PANI is 
utilized to create an electron-impeding layer on the biosensor surface since 
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being a well-studied conducting polymer PANI is best known for its electron-
conducting properties. However, as we know, PANI can exist in insulating, 
semiconducting, and conducting state depending on its doping state (usually 
H+ doping in a strong acid). It was reported that the conductivity of PANI drops 
precipitately with increasing pH and it is converted to an excellent insulator in 
alkaline medium.252 Instead of further exploiting the most popular conducting 
and electroactive properties of PANI for the development of chemical and 
biosensing devices as it has been demonstrated in numerous reports,253 this work 
for the first time exploited the possibility of leveraging on the excellent 
insulating power of PANI to develop an EIS biosensor for miRNA expression 
profile analysis. 
 
To test the feasibility of utilizing the electron insulating property of PANI as a 
sensitive signal generator for the EIS biosensor, a synthetic miRNA let-7b was 
examined at a biosensor coated with PNA CPs fully complementary to let-7b. 
For comparison, a totally non-complementary synthetic RNA of the same length 
as let-7b (control) was also tested. As seen in Figure 5-3A, after a period of 
60 min hybridization and subsequent 30 min incubation in the PANI deposition 
cocktail, a distinct difference between let-7b and the control was obtained. The 
EIS spectrum of the let-7b biosensor was made of a semicircle at high 
frequencies and a straight line with a phase angle of 45° at low frequencies 
(Figure 5-3A trace 1). The straight line with 45° phase angle is less important 
because it is related to the solution diffusion process of the redox probes, known 
as Warburg impedance.67 In the case of EIS-based biosensors, characteristics of 
the diffusion process of the redox probes are largely independent of the 
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biosensing processes. The semicircle in the EIS spectrum, on the other hand, is 
closely associated with the charge-transfer of the redox probes and its diameter 
is Rct – a direct measure of the charge-transfer process.67 The large semicircle 
observed at the let-7b biosensor indicated that a layer of charge-transfer 
impeding material exists at the biosensor surface. In contrast, a straight line with 
a phase angle of 45° was obtained in the whole frequency range at the control 
(Figure 5-3 A trace 2),67 implying that Rct in this case is largely insignificant. 
In addition, a much less significant difference was observed between the control 
and the biosensor after hybridization and before PANI deposition (Figure 5-1). 
Because the control is completely non-complementary to the PNA CPs, none of 
the miRNA strands is expected to be brought to the biosensor. On one hand, in 
the presence of deprotonated cysteine on the biosensor surface at pH 8.0 
(hybridization buffer), nonspecific uptake of the control miRNA is effectively 
minimized. On the other hand, instead of a layer of anionic target miRNA 
strands, the protonated cysteine in the pH 3.0 PANI deposition cocktail largely 
retards the deposition of PANI. Therefore, the control biosensor should remain 
as original – the same as the blank biosensor. In addition, before the deposition 
of PANI, when the EIS spectrum is collected in the pH 12.0 phosphate buffer 
cationic Ru(NH3)6
3+/2+ alleviate electrostatic repulsion between now anionic 
miRNA and the redox probes Ru(NH3)6
3+/2+; and Ru(NH3)6
3+/2+ probes are able 
to approach the electrode surface closely. Therefore, there are no noticeable 
changes in the reversibility or Rct of Ru(NH3)6
3+/2+ between the control and the 
hybridized biosensor before PANI deposition. Apparently, the 
large Rct observed with the let-7b miRNA is closely associated with the target 
hybridization and PANI deposition processes – a key parameter (analytical 
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signal) in EIS biosensors. Values of Rct can be conveniently extracted from the 
EIS spectrum by either direct analysis of the spectrum or by fitting the spectrum 
to a Randle equivalent circuit (Figure 5-3 A inset). The large Rct indicated that 
a large amount of charge-transfer impeding material is present at the biosensor 
surface as a direct consequence of let-7b hybridization and it is possible to 
realize sensitive miRNA detection via the DNAzyme-catalyzed polymerization 
of aniline and hybridized miRNA strand-guided deposition of PANI. Upon 
hybridization, the target let-7b strands are brought to the biosensor surface by 
their complementary CPs. A subsequent incubation in the PANI deposition 
cocktail results in the formation of a thin PANI film alongside the hybridized 
miRNA strands, akin to that of HRP-catalyzed polymerization of aniline and 
DNA-guided deposition of PANI.250, 251 Supportive evidence of the formation 
of the charge-transfer impeding PANI film on the biosensor surface was found 
in voltammetric test of the biosensor (Figure 5-3 B). Unlike the control which 
displayed the usual reversible voltammogram of Ru(NH3)6
3+/2+ with a peak-to-
peak potential separation (ΔEp) of 59 mV (Figure 5-3 B trace 2), a quasi-
reversible voltammogram with smaller peak currents and a larger ΔEp of 95 mV 
was obtained with let-7b (Figure 5-3 B trace 1), again suggesting the presence 
of a charge-transfer impeding layer on the biosensor surface. The smaller peak 
currents and the larger ΔEp are direct consequence of the resistance to charge 
transfer between the substrate gold electrode and Ru(NH3)6






Figure 5-3. (A) EIS spectra and (B) the corresponding voltammograms at 
100 mV/s of a let-7b biosensor to (1) 100 fM let-7b and (2) 100 fM control RNA. 
60 min hybridization at 50 °C and 30 min incubation in pH 3.0 of 0.10 M 
potassium phosphate containing 10 μM DNAzyme, 20 mM aniline, and 
200 mM hydrogen peroxide. Insets: Randle equivalent circuit used to fit the EIS 
data: Rs – solution resistance, Cdl – double layer capacitance, Rct – charge-
transfer resistance, W – Warburg impedance element. 
 
5.3.3 Optimization 
Owing to unique attributes of miRNAs, there is little room to fine-tune the 
miRNA hybridization conditions. Our efforts were therefore focused on the 
optimization of the signal amplification (PANI deposition) process. In the case 
of PANI deposition, the deposition rate must be determined by one or a 
combination of the following: (i) mass-transport processes of aniline and 
hydrogen peroxide in solution, (ii) DNAzyme-catalyzed polymerization of 
aniline, which is dependent on the concentrations of DNAzyme, aniline, and 
hydrogen peroxide, and (iii) miRNA-guided deposition of PANI. Under 
selected experimental conditions, when both the mass-transport and aniline 
polymerization are much faster than the PANI deposition process, the PANI 
deposition rate is then solely controlled by the number of the hybridized miRNA 
strands on the biosensor surface, and thus, by the concentration of the target 
114 
 
miRNA. This sole miRNA-controlled process can be achieved by “speeding up” 
polymerization and mass transport. High mass-transport rates are obtainable 
when working with high concentrations of the reactants. It is critical that the 
polymerization of aniline should be carried out in an acidic medium with a pH 
value far below then pKa of aniline (pKa = ~ 4.6),
254 so as to create a favorable 
environment for the polymerization of aniline (fast polymerization rate), to 
effectively utilize the hybridized miRNA strands as templates to guide the 
deposition of PANI, and to minimize indiscriminative deposition of PANI by 
forming electrostatic adducts along miRNA strands between cationic aniline 
molecules and anionic phosphate moieties. Unfortunately, most natural 
enzymes are active and stable only around neutral pH values. In contrast, the 
chemical nature of the DNAzyme may be stable and remain active in a much 
wider pH range, thus well-suited for this purpose. To verify this hypothesis, we 
first evaluated the catalytic activity of the DNAzyme in the polymerization of 
aniline and the deposition of PANI. It was found that the catalytic activity 
toward the polymerization of aniline and deposition of PANI is strongly pH 
dependent, attaining its maximal activity in the pH range of 2.5–3.0 (Figure 5-
4 A), reflected by the largest Rct observed. The amount of PANI found at the 
biosensor surface dropped sharply to a negligible level once the solution of pH 
was higher than 5.0, evidently due to a much lower polymerization rate and 
weaker interaction between aniline and hybridized miRNA strands. No PANI 
deposition was detected when the pH of the PANI deposition cocktail was > 6.0. 
Figure 5-4 B shows the effect of the DNAzyme on Rct of the biosensor. It was 
noted that as the DNAzyme concentration was increased, Rct increased rapidly 
and almost linearly at first, but then slowly became practically independent of 
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DNAzyme concentration at ≥ 10 µM, implying that the deposition of PANI is 
now solely controlled by the amount of hybridized miRNA strands on the 
biosensor surface. Further increase in DNAzyme resulted in excessive 
polymerization of aniline and an appreciable increase in Rct of the control, 
probably due to nonspecific deposition of PANI in the presence of large 
excesses of PANI in the cocktail. As seen in Figure 5-4 B, Rct of the control 
increased significantly from ~ 5 to 25 Ω cm2 in the PANI deposition cocktail 
containing 20 µM DNAzyme, 20 mM aniline, and 200 mM hydrogen peroxide, 
thus deteriorating the LOD from femtomolar to picomolar levels. Therefore, 5–
10 µM DNAzyme was chosen to ensure sufficiently high sensitivity and good 
signal-to-noise ratios. Unlike HRP which can be easily deactivated by pH and 
high concentrations of hydrogen peroxide, as a small HRP-mimic, the 
DNAzyme is expected to be very robust. Indeed, the DNAzyme was found to 
be much more tolerant than HPR in terms of reaction conditions. For example, 
it was observed that the DNAzyme remains active in a much wider range of 
hydrogen peroxide concentration of 10 μM to 400 mM, where enzyme like HRP 
is quickly deactivated at hydrogen peroxide concentrations > 10 mM. 
 
In addition, it was observed that a moderate amount of aniline (20 mM) 
produces the best result Figure 5-4 C. Too low an aniline concentration resulted 
in a slow polymerization and possibly a quick depletion of aniline. Too much 
aniline in the PANI deposition cocktail may lead to the formation of highly 
soluble oligomers and low molecular weight of PANI, thus reduced the PANI 






Figure 5-4. Dependence of Rct on (A) pH, (B) DNAzyme, (C) aniline, and (D) 
hydrogen peroxide; after 60 min hybridization of 250 fM let-7b at 50 °C. Data 
points represented six replicates. 
 
As for hydrogen peroxide, a high enough concentration of hydrogen peroxide is 
the prerequisite for maximizing the amplification power of the DNAzyme. The 
high concentration of hydrogen peroxide ensures that there is no substantial 
depletion of hydrogen peroxide and the PANI deposition is totally independent 
of hydrogen peroxide, which in turn infers that the amount of PANI deposited 
on the biosensor surface would scale up with the amount of the number of 
hybridized miRNA strands and the incubation in the PANI deposition cocktail. 
As shown in Figure 5-4 D, Rct of the biosensor was maximized in the presence 
of ≥ 100 mM hydrogen peroxide. 
 
Since the hybridized target miRNA-guided deposition of PANI is 
cumulative, Rct is also closely associated with the incubation time in the PANI 
deposition cocktail. High sensitivity and low LOD are expected if the deposition 
of PANI is allowed to proceed for a sufficiently long period of time. To leverage 
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on the PANI deposition for sensitivity improvement, a series of EIS tests were 
carried out with different incubation time in the PANI deposition cocktail.  
 
 
Figure 5-5. Dependence of Rct of (1) 10 fM, (20) 250 fM, and (3) 5.0 pM let-
7b after 60 min hybridization at 50 °C on the incubation time in pH 3.0 of 
0.10 M potassium phosphate containing 10 μM DNAzyme, 20 mM aniline, and 
200 mM hydrogen peroxide. Data points represented six replicates. 
 
A plot of Rct at different incubation time is shown in Figure 5-5. In all cases, 
an immediate increase in Rct was observed due to the formation of the charge-
transfer impeding PANI films on the biosensor. At 10 and 250 fM let-7b, Rct of 
the biosensor was found to be proportional to the incubation time throughout 
(Figure 5-5 traces 1 and 2), suggesting that there is very little activity loss of the 
DNAzyme during the incubation; whereas at a much higher concentration of 
5.0 pM let-7b, Rct of the biosensor gradually leveled off after an initial linear 
increasing phase (Figure 5-5 trace 3). The deviations from linearity after a 
prolonged period of incubation is probably due to the fact that Rct of the 
biosensor has reached such a high value that further deposition of PANI has 
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significantly less impact on it. Eventually, Rct of the biosensor may reach a 
steady state when the target concentration is sufficiently high and the incubation 
time is sufficiently long. It was found that a period of 30 min incubation is 
sufficient for the detection of femtomolars of miRNAs. 
 
5.3.4 Analytical performance of the biosensor 
 
Figure 5-6. Calibration curves for let-7b. 60 min hybridization at 50 °C and 30 
min incubation in pH 3.0 of 0.10 M potassium phosphate containing 10 μM 
DNAzyme, 20 mM aniline, and 200 mM hydrogen peroxide. Data points 
represented six replicates. 
 
Under optimized experimental conditions, standard solutions of synthetic 
miRNA let-7b were used to evaluate the performance of the biosensor. As 
shown in Figure 5-6, a linear relationship between Rct and let-7b concentration 
was observed from 1.0 fM to 5.0 pM with a regression coefficient of 0.97 and a 
relative standard deviation of ~ 14% at 100 fM. The LOD of the biosensor was 
estimated to be 0.50 fM at a signal/noise ratio of 3.0 (the standard deviation 
in Rct of six independent control biosensors was taken as the noise). As 
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compared to previously reported EIS miRNA biosensors, the improved 
sensitivity and decreased LOD are likely originated from the highly efficient 
polymerization and deposition of PANI. Lower LOD was attainable with a 
longer hybridization and PANI deposition time. 
 
The capability of the biosensor in selectively detecting specific miRNAs in a 
miRNA family was evaluated by analyzing three representative members of let-
7 family, namely fully complementary (let-7b), one-base-mismatched (let-7c), 
and two-base-mismatched (let-7a). As seen in Figure 5-7, a 95% and 99% drop 
in Rct were observed when let-7c and let-7a were tested on the let-7b biosensor, 
respectively. In other words, selectivity factors of 20 and 100 were observed 
with one-base mismatched and two-base mismatched miRNAs, respectively. 
Negligible responses, indistinguishable from that of the control, were observed 
when miRNAs with three or more bases are mismatched. This level of mismatch 
discrimination ability between complementary and mismatched sequences is 
better than those of many hybridization-based biosensors,35 most probably due 
to the much higher sequence selectivity of PNA.255 Unlike thermal 
amplifications employed in ligase chain reactions and qPCR, without a 
denaturing step the proposed biosensor is less prone to interferences from pre-
miRNAs since their highly stable hairpin structures remain intact under the 
hybridization conditions, making miRNA regions inaccessible for hybridization 
to the PNA CPs. A selectivity factor of ~ 40 was obtained when equal molars 





Figure 5-7. EIS responses (Rct) of a let-7b biosensor to 100 fM of let-7b, let-
7c, let-7a, let-7e, and pre-let-7b, respectively. 60 min hybridization at 50 °C and 
30 min incubation in pH 3.0 of 0.10 M potassium phosphate containing 10 μM 
DNAzyme, 20 mM aniline, and 200 mM hydrogen peroxide. Data points 
represented six replicates. 
 
Table 5-2. Comparison with other electrochemical detection methods for 
miRNA  










20:1 1.5 hrs + + + + + + + + + 
 This 
work 





Not realized 3 hrs + + +  + + +  256 





15:1 40 min + + + +  + + +   257 





Not realized 5 hrs + +  + + + + 258 
       




40:1 4 hrs + + + + + + 259 
       
 
The proposed bioassay for miRNA here was also compared with its 
electrochemical counterparts. As summarized in Table 5-2, compared with the 
previously published miRNA detection methods, the present work exhibited a 
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good repeatability as well as selectivity toward one-base mismatched miRNA 
family member. Some of the works have achieved ultralow LOD down to 
several attomolar, however, they can not distinguish a specific miRNA among 
its family members with high sequence similarity. And some of them achieved 
comparable sensitivity, LOD and selectivity but sacrificed the simplicity. 
 
5.4 Conclusion 
The present study demonstrated a biosensor for miRNA expression profiling. 
The combination of the charge neutral PNA CPs and the guided deposition of 
PANI leads the unique amplified label-free EIS biosensor for miRNAs. Without 
the need for miRNA labeling, the assay procedure is greatly simplified. The 
adoption of the guided deposition of PANI provides a convenient means of 
sensitivity improvement and LOD decreasement. Being capable of analyzing 
miRNAs without thermal cycling and with minimal sample preparation, the 
proposed biosensor is an attractive candidate for the development of a simple 
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In summary, the projects presented in this thesis were carried out successfully 
to establish highly sensitive and selective bioassays for the detection of disease-
related nucleic acids, including DNA with SNPs and abnormally expressed 
miRNAs.  
 
In Chapter 2, a ferrofluid-based homogeneous bioassay for highly sensitive and 
selective detection of disease-related SNPs was established. Excellent 
selectivity and sensitivity as well as low LOD were accomplished in this assay 
through the engagement of the FNPs and LCR. Firstly, colloidal MNPs with 
PAA coating on their surface were modified with the two types of 
oligonucleotides to prepare highly water soluble FNPs. Efficient homogeneous 
hybridization between target DNA and the oligonucleotides on FNPs was 
carried out and the first-step amplification was achieved by the incorporation of 
LCR, in which a minute amount of target DNA crosslinks millions of the FNPs 
together forming the aggregates of the FNPs. Separation of the aggregated FNPs 
from the free ones was realized simply based on their drastic difference in 
magnetic field strength under an external magnetic field. The intrinsic 
peroxidase-like activity of the FNPs was then utilized to produce a detectable 
colorimetric signal – the second step of amplification. The sensitivity was thus 
greatly improved and LOD was successfully decreased by these two 
amplification processes. The excellent sensitivity and low LOD were realized 
through the judicious design of the two types of the FNPs with SNPs located at 
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the ligation site as well as employing the allele-specific enzymatic LCR, the 
latter is proved to be more specific than PCR regarding SNP genotyping. 
 
Since it is a work of methodology development, most of the proof-of-concept 
experiments were conducted with synthetic nucleic acid samples. In other words, 
the proposed assay was only realized when the matrix effect was negligible and 
has not yet been applied to real samples. More detailed investigations and real-
sample analysis can be done to further validate that the established assay can be 
a prospective tool for uses in SNP detection at point-of-care. For example, the 
colloidal MNPs prepared in Chapter 2 has a size of 6–8 nm and this is the only 
material we employed to fabricate FNPs for SNP bioassays. Theoretically, all 
the colloidal MNPs under 10 nm should have the properties we expected for this 
bioassay. Considering that nanomaterials have dramatically different 
performances when the size varied, colloidal MNPs with other sizes may also 
be tried out in order to pursue the best performance when analyzing real samples. 
 
As a whole view of SNP genotyping and quantification, rapid advances in SNP 
research have offered an excellent opportunity to exploit SNPs for the purpose 
of providing better diagnosis, prognosis and therapeutic assessment of human 
disease. Robust, effective, and highly-specific SNP genotyping and 
quantification techniques are therefore necessary for the study of SNPs and 
diagnosis of disease. Despite impressive progress in research and development 
of SNP genotyping and quantification techniques and multiplexing strategies, 
no technique clearly represents a fundamental breakthrough. The most difficult 
challenge may be the need to assess a large number of SNPs simultaneously. 
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Judging from the speed with which new genotyping and quantification 
techniques are being developed, there is great hope that an ideal SNP 
genotyping and quantification platform will be developed in the near future. 
Future efforts should therefore be devoted to development of SNP genotyping 
and quantification techniques with enhanced sensitivity, selectivity, 
multiplexing capability, decreased LOD, and greatly simplified protocols 
without requiring any thermal amplifications. One possible approach is to 
couple isothermal amplifications to allele-specific hybridization and a simple 
signal-read-out mechanism, such as litmus test260 and colorimetry.261 Unlike the 
thermal amplification strategies employed in many of the allele-specific 
enzymatic reaction-based techniques, such as LCR and PCR, isothermal 
protocols are more advantageous in the development of robust, easy-to-use SNP 
genotyping and quantification platforms, which may eventually bring SNP 
genotyping and quantification to point-of-care.    
 
In Chapter 3, a simple and highly sensitive assay for disease-related miRNA let-
7a was developed by using MB-carried DNA detection probes coupled with 
DSN-facilitated isothermal target cycling amplification. The proposed assay for 
the detection of the target miRNA exhibited good sensitivity and selectivity as 
well as low LOD, which should be attributed to the judicious design of the assay. 
Firstly, the DNA detection probes were robustly attached to the MB carriers 
through the strong interaction between the biotin moieties on the DNA detection 
probes and the streptavidin moieties on the surface of the MBs. The dissociation 
constant of biotin-streptavidin conjugates is seen to be small enough to warrant 
that the release of fluorescent reporters (fluorescein) is only caused by the 
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presence of target miRNAs. Secondly, the utilized DSN selectively cleaved the 
DNA probes in the miRNA-DNA duplexes and released the target miRNA 
strands back to solution, thereby establishing a target recycling amplification 
mechanism. Such an accumulative nature of the target cycling amplification 
offers a powerful means to significantly improve the sensitivity and decrease 
the LOD of the assay. Moreover, the high specificity of the DSN to perfectly 
matched duplexes endows this assay a good selectivity when analyzing target 
miRNAs with high sequence similarities. Thirdly, the MBs ensure a complete 
removal of possible interference from unreacted DNA detection probes before 
fluorescence measurements, thus producing an ultralow fluorescence 
background and an extended dynamic range.  
 
The proposed assay was applied to analyze let-7a in three total RNA samples 
extracted from cultured cells to evaluate its practicability. The results obtained 
by the proposed assay agreed well with those obtained by the classic qRT-PCR 
method, indicating that this assay is reliable for miRNA detection. Compared to 
the qRT-PCR-based assays,262-264 the isothermal amplification via the DSN 
facilitated target cycling together with its excellent selectivity is very valuable 
since the freedom from thermal cycling would greatly improve the adaptability 
of the assay for direct miRNA expression profiling with minimal requirement 
of sample preparation. The simplicity, high sensitivity, low LOD, and freedom 
from thermal amplification and miRNA tagging are some of the interesting 
features for the development of a simple, robust, low cost, and highly sensitive 
miRNA expression profiling tool used at point-of-care, which is of great 
importance for early disease diagnosis and timely disease prevention. In 
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addition, future work of real sample detection without sample pre-treatment 
may be applied considering that without the denature step in isothermal assay, 
pre-RNA with hairpin structure would not induce significant false signal and 
thus would not affect the results of this assay. This is quite advantageous for 
uses at point-of-care. 
 
The final output fluorescent signals responding to target miRNAs at low 
concentrations are relatively small. In the future work, fluorophores exhibiting 
more intensive fluorescence such as Yakima yellow265 may be used to replace 
fluorescein as the fluorescent reporter to modify the DNA detection probes. In 
such a way, signals of different concentrations of target miRNAs at low 
concentrations can differ from each other more distinctively, and therefore, the 
assay could be more sensitive. Other fluorophores except the most popular 
fluorescein were not been tried because that as long as the assay works and the 
results are relatively good, the purpose of the project is achieved since we are 
focused on methodology development.  
 
The proposed assay demonstrated a detection method that only one miRNA 
family member was analyzed each time. Multiplex detection using multiple 
DNA capture probes on the MBs can be tried out in future research.  
Theoretically, multiplex detection of more than one miRNA family member can 
be achieved in a single tube undergone the same isothermal amplification 
process provided that the emission spectra of different fluorophores are not 




In Chapter 4, a novel method for the synthesis of PANI in an acidic aqueous 
medium, based on a G-quadruplex-hemin DNAzyme-catalyzed oxidation and 
polymerization of aniline by hydrogen peroxide in the presence of a polyanionic 
template, was demonstrated and well-studied for the first time. The kinetics of 
the polymerization was found to be described by the classical Michaelis-Menten 
mechanism. The linear correlation between the initial polymerization rate and 
the concentrations of aniline and hydrogen peroxide were established, which 
brings great benefit for its applications in bioassays. The synthesis is simple and 
robust, and the experimental conditions are mild and environmentally friendly. 
Due to these attractive features, this synthetic method was employed in Chapter 
5 for disease-related miRNA detection. 
 
In Chapter 5, a highly sensitive impedimetric miRNA bioassay was developed 
on the basis of hybridized miRNA-guided deposition of PANI. A gold electrode 
coated with charge neutral PNA CPs was first hybridized to target miRNAs. 
The G-quadruplex-hemin DNAzyme catalyzed polymerization of aniline 
demonstrated in Chapter 4 was then carried out, followed by the deposition of 
PANI guided by the hybridized miRNA strands, thus resulting in the formation 
of a thin PANI film on the surface of the gold electrode. The electro-transfer 
impeding power of the PANI film was utilized to determine the concentration 
of the target miRNA. Ultralow LOD down to lower femtomolar and superior 
mismatch discrimination capability of this impedimetric bioassay was observed. 
These should be largely due to the excellent hybridization selectivity of the PNA 




When comparing Chapters 3 and 5, we can see that there is a similarity between 
MBs and the gold electrode, i.e. both of them are used as carriers for CP 
immobilization and can provide convenience when separating products from the 
reaction mixture. Although MBs cannot replace the gold electrode mainly 
because the gold electrode is essential for generating an electrochemical signal, 
whereas the MBs could not even though they can be used in a way like the gold 
electrode is used to some extent. Also, after some minor adjustments for signal 
production, a series of new homogeneous bioassays could be constructed from 
the heterogeneous ones, and they are expected to exhibit similar performance 
but better repeatability.   
 
All in all, the proposed bioassays for disease-related nucleic acids in this thesis 
are still at proof-of-concept stage. Although one of them (project in Chapter 3) 
has already obtained good sensitivity and selectivity as well as low LOD when 
applied to real samples, it does not automatically ensure these assays a wide 
spread applications or even commercialization. From application point of view, 
the bioassay reported in Chapter 3 is the most possible one that can be widely 
adopted and commercialized because it is one-step, isothermal, simple, fast, 
reliable, and repeatable with relatively good selectivity and sensitivity as well 
as low LOD. In addition, since most of the materials employed in the assay are 
already commercially available, it implies that the assay are closer to 
commercialization compared with other bioassays developed in this 
thesis. Moreover, the possible property of free from pre-treatment is absolute 
advantageous in point-of-care applications. These attractive features should be 
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born in mind when we are developing a reliable and practical bioassay for the 
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